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Informed Consent and Psychotherapy: Apples and
Oranges in the Garden of Doctrine1
Judge Stephen Hjelt*
INTRODUCTION
The amount written about the doctrine of informed consent in the
last forty years truly threatens more than one old growth forest. If one
searches any of the legal, medical or psychology databases (Westlaw,
Medline, Psych-Info), one ends up with "hits" that literally number in
the thousands. These writings have increased almost exponentially in
the last fifteen years.2
The writings on informed consent are not confined to the dry
professional literature of law reviews and psychology journals. They
are found in case law, statutes, the ethical principles for medicine and
various mental health disciplines, as well as texts, specialty and popular
writings. Quite simply, at least on paper, this growth in the literature on
informed consent is ubiquitous and has, one would suppose, transformed
the relationship of patient and caregiver.
The reality, however, is far different. Despite its apparent ubiquity,
informed consent has failed to transform the essence of the treatment
encounter between doctor and patient or psychotherapist and patient.
Informed consent first developed in the context of the delivery of
medical services. Informed consent purported to alter the decision-
making fulcrum and place decision-making authority in the hands of the
patient. The results in the medical world have been decidedly mixed,
although it is incontestable that some form of informed consent is
1. This article is in partial fulfillment of the requirement for the Master of Judicial
Studies degree program at the University of Nevada, Reno.
* Judge Stephen Hjelt is an Administrative Law Judge II with the California Office of
Administrative Hearings. Judge Hjelt received his B.A. from UCLA in 1968, his J.D. from
UCLA in 1972 and his M.J.S. (Master of Judicial Studies) from the University of Nevada,
Reno in 2001. Judge Hjelt gratefully acknowledges the assistance of the following:
Professors James Richardson, David Faigman, Richard Bjur, Elizabeth Francis, Susan
Sarnoff and Stuart Zola, Dr. Steven Bucky and Dr. Jeffrey Younggren, Judge Joyce
Wharton, R. Christopher Barden, Attorney at Law, and Heather Cline Hoganson, Attorney at
Law.
2. E.g., JAY KATZ, THE SILENT WORLD OF DocTOR AND PATIENT (1984); RUTH R. FADEN
& TOM L. BEAUCHAMP, A HISTORY AND THEORY OF INFORMED CONSENT (1986). Despite the
huge volume written about informed consent, any exploration of the doctrine must include
these two extremely influential books.
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practiced somewhere, somewhat, sometimes.3
In the mental health field, informed consent is characterized by a very
weak presence despite its ostensible centrality to the delivery of ethical
care and explicit expression in the ethical principles at the core of the
profession.4  In the day-to-day delivery of mental health services,
informed consent often appears to be missing in action.
In the last decade, many viewed informed consent as a quality control
device designed to ensure consumer protection. This is based on a
misreading of the doctrine of informed consent. Informed consent exists
to promote individual autonomy and self-determination, a very different
concept than consumer protection.
Psychotherapy is the principle product, good, or service of the mental
health profession. It is a treatment that can do great good or great harm.
It is a functional analog to a drug or medical device. It can relieve
symptoms and resolve conditions. It can cure. It can kill. It can also
cause adverse reactions. Like any drug or medical device,
psychotherapy has contraindications as well as dose-specific impacts.
There have been countless new and emerging psychotherapy
techniques developed and used on patients in the last forty years. Many
are questionable, lacking in any showing of efficacy. Some do actual
harm.5 They continue to multiply and proliferate despite any showing of
efficacy and in the face of a well-developed doctrine of informed
consent.
The consequence of this is not some isolated mismatch of
psychotherapy technique and patient. The result is enormous
3. See generally, STEPHEN WEAR, INFORMED CONSENT: PATIENT AUTONOMY AND
CLINICAL BENEFICENCE WITHIN HEALTH CARE (2d ed., Georgetown Univ. Press 1998)
(1993).
4. AM. PSYCHOLOGICAL ASS'N ETHICS CODE § 4.02 (1992). Section 4.02 clearly states:
Psychologists obtain appropriate informed consent to therapy or related
procedures, using language that is reasonably understandable to participants.
The content of informed consent will vary depending on many
circumstances; however, informed consent generally implies that the person(1) has the capacity to consent, (2) has been informed of significant
information concerning the procedure, (3) has freely and without undue
influence expressed consent, and (4) consent has been appropriately
documented.
Id.
5. See e.g., DANIEL T. MAYS & CYRIL M. FRANKS, NEGATIVE OUTCOMES IN
PSYCHOTHERAPY AND WHAT TO DO ABOUT IT (1985); JAMES L. KELLEY, PSYCHIATRIC
MALPRACTICE: STORIES OF PATIENTS, PSYCHIATRISTS AND THE LAW (Rutgers University
Press 1996); MARYBETH F. AYELLA, INSANE THERAPY: PORTRAIT OF A PSYCHOTHERAPY
CULT (1998); CAROL L. MITHERS, THERAPY GONE MAD (1994); MARGARET T. SINGER &
JANJA LALICH, CRAZY THERAPIES (1996).
economically, socially and politically. Billions of dollars are
misallocated and misspent on seemingly questionable psychotherapy
techniques. 6  Human suffering from mental illness and emotional
distress continues at astronomical cost. Billions of dollars are misspent
on what may be contemporary patent medicines of the mind.7
This article explores the development of the doctrine of informed
consent, first in medicine and then in the mental health field. It also
explores the history of psychotherapy as the primary method of
treatment for mental illness and emotional distress. It then analyzes the
reasons for the proliferation of new and emerging psychotherapy
techniques, even as the doctrine of informed consent became
commonplace. This article will next propose a two-fold solution. The
first is a newly energized conception of informed consent in the mental
health field. The second is the implementation of a regulatory
mechanism akin to the Food and Drug Administration ("FDA") that will
allow the use of psychotherapy techniques only after demonstration that
the technique is safe and effective.
8
Legal commentary has often used the metaphor of the garden to
describe the growth and development of particular areas of the law. It is
a comfortable metaphor because growth, development and the fruit of
the labor well describe both the products of the garden and the law.
The growth of the doctrine of informed consent can certainly be
viewed through the prism of this metaphor. However, the
jurisprudential garden has yielded some very curious fruit. The doctrine
is well developed, yet ripe, with all the appearance of a fine apple.
However, when consumed, it tastes far more like an orange.
I. INFORMED CONSENT AS THE PRODUCT OF SOCIAL FORCES
The doctrine of informed consent is a product of powerful social
forces that have developed over the last century. The atrocities
committed by the Nazi doctors9 and the notorious cases of research-
6. NANCY E. MILLER & KATHRYN M. MAGRUDER, THE COST EFFECTIVENESS OF
PSYCHOTHERAPY: A GUIDE FOR PRACTIONERS, RESEARCHERS, AND POLICYMAKERS (Nancy E.
Miller & Kathryn M. Magruder eds., 1999).
7. Ild.
8. This is one of the basic positions taken by Division 12, the Division of Clinical
Psychology, of the American Psychological Association. A task force within Division 12 is
actively working on developing treatment protocols based on empirically supported
therapies.
9. See FADEN & BEAUCHAMP, supra note 2, at 153. Faden and Beauchamp wrote:
[T]he Nazi experiments were in many respects unprecedented in the
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subject abuse in the United States, including the Tuskeege Airmen10 and
the Jewish Chronic Disease Hospital, I' were potent factors. At the same
time, and particularly in the last forty years, our social and cultural
landscape has been transformed by a new consciousness of individual
rights. 12
The most dramatic change is what Lawrence Friedman calls "legal
culture," which he defines as "the ideas, attitudes, values, and opinions
extensiveness and extremity of the harm and suffering to which they
knowingly exposed their victims. Using subjects drawn from the populations
of concentration camps (Jews, gypsies, Poles, and Russians), Nazi scientists
explored the effects of ingesting poisons, intravenous injections of gasoline,
immersion in ice water, and the like. Infection with epidemic jaundice and
spotted fever virus were typical parts of "medical" experiments.
Id.
10. Id. at 165-66. One of the most notorious cases of prolonged and knowing violations
of subjects rights emerged in the 1970s. Id. at 165. It began in the early 1930s, when the US
Public Health Service compared the health and longevity of an untreated syphilitic
population with a nonsyphilitic but otherwise similar population. Beginning in 1932, the
study traced the pathological evolution of syphilis in approximately 400 black males using
another 200 without syphilis as controls. Id. The subjects were never told the name or the
nature of their disease. Id. They were told only that they were receiving free treatment for
"bad blood," a term local blacks associated with a host of unrelated ailments. Id. This
experiment continued until 1973. Id. During the entire forty-year period, untreated subjects
were systematically blocked from receiving available treatments. Id. This continued despite
the fact that by 1936 it was clear that complications beset many more infected subjects than
controls and within another ten years it was apparent that the death rate of those with
syphilis was twice as high as for controls. Id. at 166.
11. In 1963, a research study was conducted at the Jewish Chronic Disease Hospital inNew York. Id. at 161. A prominent cancer researcher was interested in the role of the
body's immune system in defense against cancer. Id. He received permission from the
hospital medical director to inject twenty-two patients who were cancer free with a
suspension of live cancer cells. Id. None of the twenty-two were told they were being
injected with cancer cells. Id.
12. See id. at 87. The authors continued:
Perhaps the most accurate explanation is that law and ethics, as well as
medicine itself, were all affected by issues and concerns in the wider society
about individual liberties and social equality, made all the more dramatic by
increasingly technological, powerful, and impersonal medical care ... it
seems likely that increased legal interest in the right of self-determination and
increased philosophical interest in the principle of respect for autonomy and
individualism were but instances of the new rights orientation that various
social movements of the last 30 years introduced into society. The issues
raised by civil rights, women's rights, the consumer movement, and the rights
of prisoners and of the mentally ill often included health care components:
reproductive rights, abortion and contraception, the right of health care
information, access to care, human experimentation, and so forth. These
urgent societal concerns helped reinforce public acceptance of the notion of
rights as applied to health care.
about law held by people in a society."' 3 The changes in law reflected
in the growth and development of informed consent are the product of
social change in the past century. 14
The immense technological, medical and scientific advances of the
twentieth century created new needs and expectations. For the first time
in human history, the pendulum of uncertainty surrounding human
existence swung favorably for mankind; disease and plague were
conquered; the atom was harnessed; the environment was somewhat
tamed; the human genome was mapped; life no longer seemed
precarious and uncertain in an immediate sense. '
5
We have traveled from the nineteenth to the twenty-first century and
from a social and legal culture of low expectations to one of high
expectations. 16 As uncertainty shrinks and all things appear possible,
society expects and demands more. Before the modem era of medicine,
physicians had understandably low expectations of medicine. With the
discoveries that transformed medicine in the last hundred years comes
increased expectation of performance and outcome. Whether
completely fair or not, people now have an expectation that medicine
will cure and prevent. The development of the doctrine of informed
13. LAWRENCE M. FRIEDMAN, TOTAL JUSTICE 31 (Reprint ed., Russell Sage Foundation
1994) (1987).
14. Id. at 42. Friedman notes:
[B]y the nineteenth century, at the latest, a new kind of society had
developed in the West: the society of technology, industry, science,
machines. Science and machines gave people tremendous control over time,
distance and destiny. This period was followed by the age of modem
medicine; then came the age of the computer. Each advance in science and
technology seemed to increase the possibility of control-over nature, over the
conditions of life. But control always required regulation, rules,
implementation; control was, and had to be, vested in law, legal process, and
the state.
Id.
15. Id. at 51. Friedman continues:
What has happened since the nineteenth century amounts to a major
revolution in legal culture as well as in the social order. Technology has
made the world over, and in so doing has vastly reduced certain kinds of
uncertainty; it has opened the door to a vastly greater level of demands on
government. Slowly people have come to expect more out of government,
out of law, out of life. The mechanisms may be obscure, but one key factor
is the sense that there are ways to exert control over many of man's ancient
contingencies. Technology is crucial in generating this sense of control.
Science and machines can conquer disease, lift the curse of early death,
protect against disaster, solve the problems of the world. And from physical
control the mind moves, in time, to social, collective control.
lt
16. Id. at 57-58.
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consent is simply one expression of the growth of expectations in a more
certain and predictable existence.
Expectations rise only when there is a possibility of fulfillment. That
is certainly the story of the last hundred years. With new expectations
comes demand for rights; the legal entitlement to the fulfillment of those
expectations. It is not mere coincidence that the growth and
development of the doctrine of informed consent in the last forty years
parallels the growth and development of new social movements in this
country. The rising tide of expectations, or "legal culture," found
expression through seminal works that helped spawn or crystallize
nascent social movements. In 1962, Rachel Carson published Silent
Spring which is credited with the birth of the ecology/environmental
movement.17  Likewise, in 1962, Michael Harrington published The
Other America which is credited with helping to shape the "War on
Poverty" and the other programs associated with Lyndon Johnson's
Great Society.18 In 1963, Betty Friedan published The Feminine
Mystique which gave impetus to the Feminist Movement.1 9 In 1965,
Ralph Nader published Unsafe at Any Speed which is associated with
the birth of the consumer safety movement.2 °
II. PRIOR SCHOLARSHIP
In 1984, a student Note in the Georgetown Law Journal explored the
application of the doctrine of informed consent to psychotherapy vis-a-
vis the early 1980s and concluded:
Psychotherapy is a commonly used method of dealing
with personal problems. Patients, however, are not
adequately protected from its risks. The doctrine of
informed consent, which functions as a barrier against
professional abuse in medical settings, generally has not
been applied to the psychotherapist-patient relationship.
Applying the doctrine of informed consent to
psychotherapy and requiring therapists to give patients an
informed consent form before they agree to enter into
therapy will ensure that patients are truly aware of all of
the risks inherent in treatment before they give the
17. RACHEL CARSON, SILENT SPRING (1962).
18. MICHAEL HARRINGTON, THE OTHER AMERICA: POVERTY IN THE UNITED STATES
(Penguin Books 1972) (1969).
19. BETTY FRIEDAN, THE FEMININE MYSTIQUE (1963).
20. RALPH NADER, UNSAFE AT ANY SPEED (1965).
therapist their consent to begin.2"
The solution suggested by the author was to formalize the informed
consent procedure by having three different documents offered to the
patient at the initial therapy session including the client's rights
statement, the initial contract form and the informed consent form.
22
The clients' rights statement and the initial contract form notify the
patient of his or her right to terminate therapy at any time.23 The
informed consent form would disclose risks of psychotherapy. 24 The
author notes that such implementation would result in substantial
benefit.
Use of these documents would be beneficial in three ways. First,
clinicians would adhere more strictly to the doctrine of informed
consent. 26  Second, by establishing a standard of disclosure, these
documents would establish a professional standard of due care against
which a court could measure the performance of a therapist when a
plaintiff claims he has been injured during psychotherapy. 27 Third, by
demonstrating the substance of a psychotherapist's disclosure, these
documents would reduce the problems of proof encountered by both
patients and psychotherapists during litigation.28
Despite almost twenty years of active development of the doctrine of
informed consent and despite the fact that it is generally acknowledged
to apply to psychotherapy, it has failed to have a significant impact on
the relation between psychotherapist and patient.
III. THE LAW OF INFORMED CONSENT
The doctrine of informed consent originally developed in the context
of the delivery of medical care. It came to define the rights and duties of
physicians and patients in their therapeutic interactions. Over time, it
came to be applied without alteration to the interactions of mental health
professionals with their patients or clients.
The law of informed consent is almost exclusively the creation of
21. Steven Horowitz, Note, The Doctrine of Informed Consent Applied to Psychotherapy,
72 GEO. L.J. 1637, 1663 (1984).
22. Id. at 1662.
23. Id.
24. Id.
25. Id.
26. Id.
27. Id.
28. Id. at 1662-63.
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courts and judges in the last forty years. This decisional law establishes
a fairly straightforward mandate regarding the duties owed to a patient
or client by a medical or mental health professional. Taken together
with the ethical practice codes of the various disciplines within the
medical and the mental health enterprise, they set forth a practice
standard by which a physician or psychotherapist's professional
behavior is judged.
Like all areas of the law, the informed consent doctrine is evolving. It
is not static, nor is it identical from state to state. 29 Nevertheless, it has a
readily ascertainable general content which practitioners ignore at their
peril.
What courts and judges have done, first in medicine and then in the
mental health field, is completely shift the decision-making fulcrum.
For almost the entire history of the healing arts, there was no notion of
informed consent. The Hippocratic Oath contained nothing about it.3"
Only in the last forty years has the doctrine emerged and taken its
uneasy place as a determinant of professional behavior. On paper at
least, the decisions of the last forty years appear to have completely
shifted control over treatment decisions from caregiver to patient.
In Canterbury v. Spence,3 1 a 1972 federal appeals court discussed the
limits of a doctor's obligation to advise his clients of risks.32 The factual
background that led to the appeal was quite straightforward. A young
man troubled with back pain submitted to surgery without being told of
the risk of paralysis.33 The surgery cured the pain, but left him
29. Richard A. Heineman, Pushing the Limits of Informed Consent: Johnson v.
Kokemoor and Physician-Specific Disclosure, 1997 Wis. L. REV. 1079, 1082-83 (1997). The
standard by which the adequacy of a caregiver's disclosure is determined is one such
example:
In its most basic form, the doctrine of informed consent states that
physicians have a duty to make adequate disclosures to patients regarding
proposed medical treatment so that patients can make knowledgeable
choices. The standard for determining the adequacy of such disclosure varies
among jurisdictions. Slightly more than half the states still look to the
original formulation, what a "reasonable medical practitioner" would provide
in the same or similar circumstances. A growing number of states, including
Wisconsin, have adopted a more patient-oriented approach. This approach
seeks to restrain medical paternalism by looking to the informational needs of
the "reasonable patient," rather than relying solely on prevailing medical
practice to determine what constitutes material disclosure.
Id.
30. STEDMAN'S MEDICAL DICTIONARY 822 (27th ed. 2000).
31. 464 F.2d 772 (D.C. Cir. 1972).
32. Id. at 776.
33. Id.
paralyzed.34 The appellate court wrote:
True consent to what happens to one's self is the informed
exercise of a choice, and that entails an opportunity to
evaluate knowledgeably the options available and the risks
attendant upon each. The average patient has little or no
understanding of the medical arts, and ordinarily has only
his physician to whom he can look for enlightenment with
which to reach an intelligent decision. From these almost
axiomatic considerations springs the need, and in turn the
requirements, of a reasonable divulgence by physician to
patient to make such a decision possible.
35
The court's recognition of the shift in decision-making authority was
crystal clear:
The context in which the duty of risk-disclosure arises
is invariably the occasion for decision as to whether a
particular treatment procedure is to be undertaken. To the
physician, whose training enables a self-satisfying
evaluation, the answer may seem clear, but it is the
prerogative of the patient, not the physician, to determine
for himself the direction in which his interests seem to lie.
To enable the patient to chart his course understandably,
some familiarity with the therapeutic alternatives and their
hazards become essential.3 6
How is the scope of this duty to be determined? In other words, by
what standard do you decide how much and what kind of information is
enough to comply with the standard of care? The doctor argued that he
should be held to the standard of what other doctors in the community
would disclose.37 The court ruled that the custom in the medical
community is not the yardstick.38 The court explained:
In our view, the patient's right of self-decision shapes
the boundaries of the duty to reveal. That right can be
effectively exercised only if the patient possesses enough
information to enable an intelligent choice. The scope of
the physician's communications to the patient, then, must
be measured by the patient's need, and that need is the
34. Id.
35. Id. at 780.
36. Id. at 781.
37. Id. at 779.
38. Id. at 796.
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information material to the decision. Thus the test for
determining whether a particular peril must be divulged is
its materiality to the patient's decision: all risks potentially
affecting the decision must be unmasked. And to
safeguard the patient's interest in achieving his own
determination on treatment, the law must itself set the
standard for adequate disclosure. 39
A thorny question naturally follows: By what method does a doctor
identify the type of information that a given patient needs? The court
here noted that it is reasonable to expect a doctor to determine what a
patient would consider important to his decision.40 A doctor must use
his medical training and experience to sense how an "average,
reasonable patient" would react.41 This court concluded:
From these considerations we derive the breadth of the
disclosure of risks legally to be required. The scope of the
standard is not subjective as to either the physician or the
patient; it remains objective with due regard for the
patient's informational needs and with suitable leeway for
the physician's situation. In broad outline, we agree that
"[a] risk is thus material when a reasonable person, in
what the physician knows or should know to be the
patient's position, would be likely to attach significance to
the risk or cluster of risks in deciding whether or not to
forego the proposed therapy."
The topics importantly demanding a communication
of information are the inherent and potential hazards of
the proposed treatment, the alternatives to that treatment,
if any, and the results likely if the patient remains
untreated.42
The health care professional's obligation to provide for informed
consent includes specifically the obligation to disclose the risk of non-
treatment.43 In Truman the California Supreme Court extended liability
to include disclosure of the risk of forgoing a diagnostic procedure.44
39. Id at 786-87.
40. Id. at 787.
41. Id.
42. Id. at 787-88.
43. Truman v. Thomas, 611 P.2d 902, 906 (Cal. 1980).
44. Id. at 904.
22-1
Rena Truman died of cervical cancer in 1970.45 She was a patient of
Dr. Thomas from ages sixty-three to sixty-nine.46 He never performed a
pap smear, which, in all likelihood, would have detected the cancer in
time to allow successful treatment.47 The California Supreme Court
framed the issue in terms of whether Dr. Thomas breached his duty of
care to Mrs. Truman when he failed to inform her of the potentially fatal
consequences of allowing cervical cancer to develop undetected by a
pap smear.48
The court held the doctor accountable.4 9 This case has far-reaching
implications for the mental health profession because their mission
involves more than just talk. It involves the diagnosis and treatment of
things that may well be biological. This could well impose obligations
of disclosure regarding the need for psychological, genetic or
neurological testing and the expected risks of a failure to have
diagnostic tests done.
In Arato v. Avedon,5° the California Supreme Court was asked to
extend the reach of the informed consent doctrine to include a
requirement that a physician disclose information to a patient that would
be material to a patient's non-medical interests.5 ' The underlying
malpractice action was brought by the wife and children of a deceased
pancreatic cancer patient.52 Plaintiffs claimed that the defendant doctor
failed to notify the decedent fully about his illness prior to treatment by
failing to disclose the decedent's low statistical life expectancy. 53 The
decedent was forty-two when cancer was discovered.54 Surgery was
performed and cancerous tissue was removed, but because of concern
that it could recur or spread, he was referred to an oncologist. 55 The
oncologist discussed with the decedent the advisability of a course of
chemotherapy which, in conjunction with radiation, had shown promise
in dealing with this type of cancer.56 Although at trial there was a
dispute about the extent of the informed consent given, the defendant
45. Id.
46. Id.
47. Id.
48. Id. at 903.
49. Id. at 912.
50. 858 P.2d 598 (Cal. 1993).
51. Id. at 599.
52. Id. at 600.
53. Id.
54. Id.
55. Id.
56. Id. at 600-01.
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admitted that neither the operating surgeon nor the oncologist
specifically disclosed to the patient or his wife the high statistical
mortality rate associated with pancreatic cancer.57  The defendants
testified that Mr. and Mrs. Arato were told at the outset of treatment that
most victims of pancreatic cancer die of the disease and that he was at
serious or great risk of a recurrence. Further, the doctor warned that
should the cancer return, his condition would be judged incurable. 8
Although he had positive results from the chemotherapy, the cancer
returned and he died one year and four days after his surgery.59
The plaintiffs argued that specific mortality information, in this case
that only five to ten percent of those afflicted live as long as five years,
was required to constitute a proper informed consent.6" Plaintiffs
claimed that if Mr. Arato had known the statistical probability of his
early death, he would have rejected chemotherapy and spent his
remaining days in peace with his family while arranging his business
and financial affairs.61 Because he lived with a false hope of cure,
plaintiffs claimed, he failed to order his affairs in contemplation of his
death.62 Plaintiffs claimed that this caused the failure of his contracting
business and substantial real estate and tax losses.63
The court began its legal analysis with homage to Cobbs v. Grant,6 4
referring to it and its companions from other jurisdictions as "one of the
epochal opinions in the legal recognition of the medical patient's
protectible interest in autonomous decision-making."65 The court then
reiterated the importance placed on setting or context that Cobbs
references. 66 The court stated:
This sensitivity to context seems all the more
appropriate in the case of life expectancy projections for
cancer patients based on statistical samples. Without
exception, the testimony of every physician-witness at
trial confirmed what is evident even to a nonprofessional:
statistical morbidity values derived from the experience of
57. Id. at 601.
58. Id.
59. Id.
60. Id. at 602.
61. Id.
62. Id.
63. Id.
64. 502 P.2d 1 (Cal. 1972).
65. Arato, 858 P.2d at 605.
66. Id. at 604.
population groups are inherently unreliable and offer little
assurance regarding the fate of the individual patient;
indeed, to assume that such data are conclusive in
themselves smacks of a refusal to explore treatment
alternatives and the medical abdication of the patient's
well-being.
67
In addition to ruling that the extent of the information given was for
the jury to decide, the court also held that the statistical data on life
expectancy should have been disclosed because it was material to
decedent's non-medical interests, his business and investment affairs
and the potential adverse impact of his death on them:
The short answer to plaintiffs' claim is our statement in
Moore that a "physician is not the patient's financial
adviser." From its inception, the rationale behind the
disclosure requirement implementing the doctrine of
informed consent has been to protect the patient's freedom
to "exercise ... control over [one's] own body" by
directing the course of medical treatment. We recently
noted that "the principle of self-determination...
embraces all aspects of medical decisionmaking by the
competent adult . . . ." Although an aspect of personal
autonomy, the conditions for the exercise of the patient's
right of self-decision presuppose a therapeutic focus, a
supposition reflected in the text of BAJI No. 6.11 itself.
The fact that a physician has "fiducial" obligations which,
as the result in Bowman illustrates, prohibit
misrepresenting the nature of the patient's medical
condition, does not mean that he or she is under a duty, the
scope of which is undefined, to disclose every
contingency that might affect the patient's nonmedical
"rights and interests." 68
Although its basic legal contours are well known, the doctrine of
informed consent continues to develop. In Johnson v. Kokemoor,69 the
Wisconsin Supreme Court significantly extended the doctrine of
informed consent to require doctors to disclose to patients comparative
risk data, as well as the availability of more experienced physicians.
70
67. Id. at 607.
68. Id. at 608-09 (citations omitted) (emphasis in original).
69. 545 N.W. 2d 495 (1996).
70. Id. at 510.
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In doing so, the Wisconsin Supreme Court extended the principle of
patient autonomy much further than previous informed consent
decisions in Wisconsin and other jurisdictions. 71
Dr. Kokemoor was a neurosurgeon who treated Ms. Johnson for an
enlarging aneurysm he diagnosed at the rear of her brain.72  He
recommended and performed surgery in October 1990.73 The surgery,
while a technical success, left Ms. Johnson an incomplete quadriplegic
unable to walk or control her bladder. In addition, Ms. Johnson
thereafter suffered from speech and vision impairment.74 At trial she
alleged that he had overstated the need for surgery and exaggerated his
level of experience in performing this type of surgery.75
The court concluded that disclosure requirements must be set by the
patients' needs and that such needs included information that a
reasonable person would deem necessary for an intelligent decision. 76
The court found that Dr. Kokemoor failed to communicate the substance
of his actual experience in performing this type of procedure as
required.77 The court next found that he had a duty to disclose
comparative risk data that would show the morbidity and mortality rates
of physicians performing a given procedure with varying degrees of
experience. 78 The court also concluded that Dr. Kokemoor had a duty to
refer her to more experienced physicians. 79 This follows logically from
the conclusion that a duty existed to disclose physician experience and
comparative risk data.80  It also represents a large extension of the
informed consent doctrine. 81
The law of informed consent in the mental health context, as applied
to psychotherapy, is not in the least bit complicated, at least in the
abstract. It has, for all practical purposes, simply been borrowed from
the law of informed consent that developed and has been applied to the
71. Richard A. Heinemann, Note, Pushing The Limits Of Informed Consent: Johnson V.
Kokemoor And Physician-Specific Disclosure, 1997 Wis. L. Rev. 1079, 1099 (1997)(providing an extensive discussion of the development of the doctrine of informed consent
and the extension of the doctrine by the Wisconsin Supreme Court).
72. Johnson, 545 N.W. 2d at 498.
73. Id.
74. Id. at 499.
75. Id.
76. Id. at 504.
77. Id. at 505.
78. Id. at 507.
79. Id. at 509.
80. Heinemann, supra note 71, at 1108.
81. Id.
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practice of medicine.82
IV. MENTAL ILLNESS AND ITS COSTS
The dawn of a new millennium characteristically provokes a variety
of social and cultural phenomena. Doomsday cults gathered and waited
for the end of the world. Those with means sought a memorable way to
usher in this new and different world. Some chose a jet plane flying to
catch the dawn on January 1, 2000. Others, perhaps less adventurous
but traditionally romantic, chose Paris. For the less sedate with the urge
to really party there was Rio de Janeiro or, if the budget was limited,
perhaps Times Square, New Orleans or Las Vegas. Even the "stay at
homes" felt compelled to observe the passing of the twentieth century
into the twenty-first.
But, despite the heady and celebratory atmosphere, few things
changed in the real world as the calendar rolled from one year to the
next. Human suffering took no vacation. Cancer and AIDS continued
to wreak havoc on the lives of countless millions throughout the world.
Indeed, sub-Saharan Africa faces the grim prospect of an AIDS
epidemic that will decimate the population of countless nations.
83
Against this contradictory tableau of celebration and misery, we wake
almost daily to new announcements of medical breakthroughs. We are
soon to see the complete mapping of the human genome and with it the
heightened promise of cure for many of humanity's greatest scourges.
No disease or problem seems beyond the ultimate reach of medical or
scientific discovery. Researchers are coming closer to understanding the
riddle of aging and with that understanding comes the prospect, literally,
of a fountain of youth.
82. 0. BRANDT CAUDILL & KENNETH S. POPE, LAW AND MENTAL HEALTH
PROFESSIONALS: CALIFORNIA 551 (American Psychological Association 1995) ("The
doctrine of informed consent was articulated first in court cases involving physicians;
however, the requirement that a patient give informed consent to treatment is equally applied
to licensed or certified MHPs [mental health professionals]"). See also Rains v. Superior
Court, 198 Cal. Rptr. 249 (Ct. App. 1984), Barclay v. Campbell, 704 S.W.2d 8 (Tex. 1986),
Aiken v. Clary, 396 S.W. 668 (Mo. 1965).
83. John Christensen, Aids in Africa: Dying by the numbers, at http://www.cnn.corn
SPECIALS/2000/aids/stories/overview/ (last visited Aug. 13, 2002). Estimates from
UNAIDS, an umbrella group for five United Nations groups, the World Bank and the World
Health Organization, are that 34.5 million people in the world have AIDS and 24.5 of them
live in sub-Saharan Africa. Of the 5.4 million new AIDS infections in 1999, 4 million are in
Africa. In 1999, 2.8 million people died worldwide of AIDS, 85 % of them in Africa; In
1999, 13.2 million children were orphaned by AIDS worldwide, 12.1 million of them in sub-
Saharan Africa. Id.
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Despite these stunning advances, mental illness continues to resist the
efforts of researchers to solve its mysteries. It is commonplace in
medical practice that diagnosis and treatment remain a challenge
because the human body does not reveal its secrets easily. The nervous
system, principally the brain, remains still mysterious and complex and,
in some ways, beyond imagination. This is not to say that advances in
the understanding of mental illness, such as schizophrenia, bipolar
disorder, major depression or obsessive-compulsive disorder have been
non-existent. Researchers all over the world continue to seek answers to
these riddles of the brain and advances have been made. However, one
of the fundamental goals of all medical research is to understand the
cause or etiology of a disorder. Successful treatment of a disease or
disorder ultimately depends on this.84
To date, unfortunately, the etiology or cause of most of these
disorders remains "unknown" and thus in a very basic sense we remain
in the dark about the cause or causes of major mental illness.85
What is mental illness? What is this "thing" that seems to possess
some human beings that makes them different from the rest. Over the
centuries, the names for these people have changed. People with mental
illnesses have been known as, hysterics, lunatics, demented, idiots, and
insane. What has not changed is their suffering and the suffering and
loss experienced by family, friends and the community at large.
Terms such as mental illness and mental health are difficult to define.
Both terms are defined by reference to different points on the same
continuum of mental functioning. Both terms are descriptive of a
condition or state of being, not a tangible thing.86
84. PAUL R. MCHUGH, M.D. & PHILLIP R. SLAVNEY, M.D., THE PERSPECTIVES OF
PSYCHIATRY 50 (Johns Hopkins 2d ed. 1998) ("Truly rational treatments, that is, treatments
that do more than ameliorate symptoms, can emerge only with the complete understanding
of the cause (etiology) of the pathological process.").
85. 2 KAPLAN & SADOCK'S COMPREHENSIVE TEXTBOOK OF PSYCHIATRY 2783 (Lippincott
Williams et al. eds., 7th ed. 2000) (describing schizophrenia as "a heterogeneous disorder of
unknown cause").
86. U.S. SURGEON GENERAL, MENTAL HEALTH: A REPORT OF THE SURGEON GENERAL 4-5(1999) available at http://www.surgeongeneral.gov/library/mentalhealth/pdfs/C 1.pdf. The
Surgeon General describes these terms as follows:
"[M]ental health" and "mental illness" are not polar opposites but may be
thought of as points on a continuum. Mental health is a state of successful
performance of mental function, resulting in productive activities, fulfilling
relationships with other people, and the ability to adapt to change and to cope
with adversity. Mental health is indispensable to personal wellbeing, family
and interpersonal relationships, and contribution to community or society. It
is easy to overlook the value of mental health until problems surface. Yet
from early childhood until death, mental health is the springboard of thinking
These terms are quite general in their definition. It is almost
impossible to define these terms with any more specificity.
Nevertheless, these terms accurately capture the qualities that
distinguish humans on that continuum that describes our mental and
emotional state.
We are only now beginning to acknowledge the huge personal and
social costs associated with mental illness.87 Recognition has come as a
result of large-scale epidemiology studies and sophisticated economic
analysis. Epidemiology studies the pattern of disease in a given
population. It is a specialty that provides crucial assistance in mapping
disease. It has its own nomenclature to describe important facts.
"Incidence" refers to new cases of a given condition occurring within a
specific period of time. "Prevalence" refers to cases (existing and new)
that exist at a given point in time or during a specific period of time.
Although estimates have varied over the years, current estimates are that
at least one in five people have a diagnosable mental disorder during the
course of a year.88
and communication skills, learning, emotional growth, resilience, and self-
esteem. These are the ingredients of each individual's successful
contribution to community and society ....
Mental illness is the term that refers collectively to all diagnosable mental
disorders. Mental disorders are health conditions that are characterized by
alterations in thinking, mood, or behavior (or some combination thereof)
associated with distress and/or impaired functioning. Alzheimer's disease
exemplifies a mental disorder largely marked by alterations in thinking
(especially forgetting). Depression exemplifies a mental disorder largely
marked by alterations in behavior (overactivity) and/or thinking (inability to
concentrate). Alterations in thinking, mood, or behavior contribute to a host
of problems-patient distress, impaired functioning, or heightened risk of
death, pain, disability, or loss of freedom.
Id.
87. Id. at 3. The Surgeon General's Report begins with this sobering statement:
The report was prepared against a backdrop of growing awareness in the
United States and throughout the world of the immense burden of disability
associated with mental illnesses. In the United States, mental disorders
collectively account for more than 15 percent of the overall burden of disease
from all causes and slightly more than the burden associated with all forms of
cancer. These data underscore the importance and urgency of treating and
preventing mental disorders and of promoting mental health in our society.
Id.
88. U.S. SURGEON GENERAL, MENTAL HEALTH: A REPORT OF THE SURGEON GENERAL 46
(1999) available at http://www.surgeongeneral.gov/library/mentalhealth/pdfs/C2.pdf. The
Report continues:
This estimate comes from two different epidemiological surveys: the
Epidemiologic Catchment area (EAC) study of the early 1980s and the
National Comorbidity Survey (NCS) of the early 1990s. Those surveys
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The cost of mental illness in terms of human misery and suffering is
extremely difficult to quantify but not terribly difficult to appreciate.
However, economists have devoted great energy and effort to
quantifying the costs of mental illness, dividing costs into direct and
indirect costs.89  When viewed in the aggregate, these costs are
staggering. 90
Dollars are the most obvious and direct measure of cost. However,
economists have developed sophisticated alternative methods to identify
and evaluate costs. Recently, a World Bank World Health Organization
publication conducted a study of the indirect costs of mental disorders in
relation to years lived with a disability, with and without years of life
lost due to premature death. 91  The study uses the term Disability
Adjusted Life Years ("DALYs") to describe the burden of disability and
premature death resulting from mental and physical disorders
throughout the world. 92 This study found that mental disorders account
for more than fifteen percent of the burden of disease in established
defined mental illness according to the prevailing editions of the Diagnostic
and Statistical Manual of Mental Disorders (i.e., DSM-II and DSM-111-R).
The surveys estimate that during a one year period, 22 to 23 percent of the
U.S. adult population- or 44 million people-have diagnosable mental
disorders, according to reliable, established criteria. In general, 19 percent of
the adult U.S. population have a mental disorder alone (in one year); 3
percent have both mental and addictive disorders; and 6 percent have
addictive disorders alone. Consequently, about 28 to 30 percent of the
population have either a mental or addictive disorder.
Id. (citations omitted).
89. Id. at 49. The Report further comments:
Direct costs correspond to spending for treatment and rehabilitation
nationwide.
When economists calculate the costs of an illness, they also strive to
identify indirect costs. Indirect costs can be defined in different ways, but
here they refer to lost productivity at the workplace, school, and home due to
premature death or disability. The indirect costs of mental illness were
estimated in 1990 at $78.6 billion (Rice & Miller, 1996). More than 80
percent of those costs stemmed from disability rather than death because
mortality from mental disorders is relatively low.
Id.
90. Id. The Surgeon General's Report does not mince words:
The costs of mental illness are exceedingly high .... The direct costs of
mental health services in the United States in 1996 totaled $69.0 Billion.
This figure represents 7.3 percent of total health spending. An additional
17.7 billion was spent on Alzheimer's disease and $12.6 billion on substance
abuse treatment.
Id.
91. THE GLOBAL BURDEN OF DISEASE (C.J.L. Murray & A.D. Lopez eds., Harvard
School of Public Health 1996).
92. d
market economies; unipolar major depression, bipolar disorder,
schizophrenia, and obsessive-compulsive disorder are found to be
among the top ten leading causes of disability worldwide.
93
Another way to view the cost of mental illness is to consider cost
from the standpoint of the utilization of mental health services for the
past several decades. For example, between 1970 and 1988, the number
of private psychiatric hospitals grew nearly 200%, from 150 to 444.
94
"Between 1965 and 1990, the number of inpatient episodes in mental
health organizations in the United States increased steadily from
1,565,525 to 2,262,474; whereas the number of psychiatry outpatient
episodes nearly quintupled from 1,071,000 to 5,810,405, and the number
of partial care admissions increased almost ten-fold from 55,486 to
544,201."95 When the dollars spent on mental health care services and
research are combined we see:
* The National Institute of Mental Health (NIMH) budget
increased from $1,119,000 in 1945 to $178,067,000 in 1979,
to over an estimated $661,290,000 in 1996, and this current
estimate does not include Substance Abuse and Mental
Health Services Administration (SAMHSA), which
represents about $2 billion in federal funding (National
Institutes of Health, 1996).
* Total Expenditures by mental health organizations in the
United States, as measured in current dollars, increased
more than eightfold between 1969 and 1990, from $3.3 to
$28.4 billion (Redick et al, 1994b). 96
The costs of mental illness are both personal and subjective as well as
collective and objective. The personal and subjective involve the
narratives of individuals and families that live with mental illness. The
collective and objective involve the cost to the nation in reduced or lost
productivity (indirect costs) and in the medical resources used for care,
treatment and rehabilitation (direct costs).
A central argument of this article is that when scarce resources are
devoted to treatments that do not work or cause harm, something more
than a misallocation of resources is happening. Such actions call into
93. Id.
94. John P. Docherty, Market-Based Health Care Reform and the Cost-Effectiveness of
Psychotherapy, in COST-EFFECTIVENESS OF PSYCHOTHERAPY: A GUIDE FOR PRACTITIONERS,
RESEARCHERS AND POLICYMAKERS 1, 3 (Nancy E. Miller & Kathryn M. Magruder eds.,
1999) (citation omitted).
95. Id. (citation omitted).
96. Id.
Informed Consent and PsychotherapySpring 2002
20 Journal of National Association of Administrative Law Judges 22-1
question the methods and motives of the profession engaged in this
activity. Regarding unproved psychotherapy techniques, those involved
include psychiatrists, psychologists, social workers, family therapists
and counselors.
V. PSYCHOTHERAPY AND ITS COSTS
Psychotherapy has many meanings and one must understand these
various meanings in order to understand and appreciate its historical and
contemporary impact. It is both a thing and a symbol, a treatment
modality and a metaphor. Its meaning and its utility depend on whether
one is a believer or a skeptic, but its social and cultural impact is
undeniable. Psychotherapy is the principal product, service or good of
the mental health profession. For reasons already alluded to, the mental
health profession has a pervasive and ever increasing impact on
American society. 97
In reflecting on the profound and far-reaching impact of the mental
health enterprise today, a social historian described psychotherapy as
"The Romance of American Psychology."98  We have come to think
97. TANA DINEEN, MANUFACTURING VICTIMS: WHAT THE PSYCHOLOGY INDUSTRY IS
DOING TO PEOPLE 17 (1996). Dineen wrote:
No matter where one turns, one finds the effects of the psychology
industry. Its influence extends across all aspects of life, telling us how to
work, how to live, how to love and even, how to play. We are confronted by
psychologists expounding their theories on the endless list of TV talk-shows
like Oprah and Geraldo, on the TV news journals and in the supermarket
tabloids, on subjects as wide ranging as the re-caps of the O.J. Simpson trial
or the epidemic of post traumatic stress disorder in Bosnia.
Id.
98. ELLEN HERMAN, THE ROMANCE OF AMERICAN PSYCHOLOGY 1 (1995). Herman
wrote:
Psychological insight is the creed of our time. In the name of
enlightenment, experts promise help and faith, knowledge and comfort. They
devise confident formulas for happy living and ambitious plans for dissolving
the knots of conflict. Psychology, according to its boosters, possesses
worthwhile answers to our most difficult personal questions and practical
solutions for our most intractable social problems.
In the late twentieth-century United States, we are likely to believe what
psychological experts tell us. They speak with authority to a vast audience
and have become familiar figures in most communities, in the media, and in
virtually every corner of popular culture. Their advice is big business. It is
taken for granted that they have a right to a central place in debates about the
current state and future direction of American society. From families to
governments, from abuse and recovery to war and urban violence, from the
mysteries of individual subjectivity to the manifest problems of our collective
social life, few institutions, issues, or spheres of existence remain untouched
by the progress of psychology in American society.
about life in psychological terms and our everyday conversation is full
of the jargon of the profession. 99 It so much a part of popular culture
that it is even in our music.100
Precise terms to describe the tasks mental health professionals do are
quite elusive. Equally elusive is a precise definition of whom it is that
provides psychological services. There was a time when mental health
services were provided by psychologists or psychiatrists. Some called
themselves psychoanalysts, claiming to strictly follow the tenets of their
master, Sigmund Freud. This is clearly no longer the case. Today we
have psychologists, psychiatrists, clinical social workers, marriage and
family counselors, as well as advisors and helpers of all different
backgrounds. Some are licensed, some are not; some have special
education and training, others do not.10 1
Similarly, the term psychotherapy has a very ambiguous meaning. It
is used in so many different ways to describe so many different things
that it is hard to know what a user really means when he or she says
"psychotherapy." This definitional ambiguity is acknowledged when
one reads the texts and treatises on psychotherapy. 102
Id.
99. For example, we speak of repression, denial, Freudian slips, defense mechanisms,
and our inner child.
100. See e.g., Eagles, Get Over It, on HELL FREEZES OVER (Black Cypress Music 1994).
The Eagles sing:
I turn on the tube and what do I see
A whole lotta of people cryin' "Don't blame me"
They point their crooked little fingers at everybody else
Spend all their time feelin' sorry for themselves
Victims of this, victims of that
Your momma's too thin; your daddy's too fat
You drag it around like a ball and chain
You wallow in the guilt; you wallow in the pain
You wave it like a flag, you wear it like a crown
Got your mind in the gutter, bringin' everybody down
Complain about the present and blame it on the past
I'd like to find your inner child and kick its little ass.
Id.
101. Ronald Fox, Training Professional Psychologists for the Twenty-First Century, 3
AMERICAN PSYCHOLOGIST 49 (1994) ("The general public often has difficulty in
understanding the differences between professional psychologists and other types of
psychologists, between professional psychologists and psychiatrists, between psychologists
and counselors, or between psychologists and a variety of other professionals who deal with
emotional, health, and behavioral problems.").
102. LEwIS R. WOLBERG, THE TECHNIQUE OF PSYCHOTHERAPY 3 (Grune & Stratton 4th
ed. 1988). Wolberg acknowledges the elusive meaning of "psychotherapy":
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One common way of defining the term is through legislation.
California's definition of the term "psychotherapy" is typical of this
approach. The statutory definition, like those definitions previously
mentioned, is broad and inherently ambiguous. 103
The Surgeon General's Report defines psychotherapy in a slightly
different fashion as a type of learning in which a mental health
Few words in the lexicon of the mental health field are as ambiguous as
the term "psychotherapy." It is loosely employed to connote, among other
meanings, helping, treating, advising, guiding, educating, and even
influencing. Definitions of psychotherapy are often bridled to fields of
disciplinary operation, e.g., psychiatry, psychology, casework etc.,
sanctuaries for such characterizations being sought in specialized societies.
This diffuseness has converted the arena of psychotherapy into a swamp of
murky ideas, fostering many divergent theories and techniques. Yet a brief
and precise description of therapy is important if no more than to
circumscribe boundaries of operation and for purposes of hypothetical
construction and empirical study.
Id. After noting the definitional challenge, Wolberg offers this definition:
Psychotherapy is the treatment, by psychological means, of problems of
an emotional nature in which a trained person deliberately establishes a
professional relationship with the patient with the object of (1) removing,
modifying, or retarding existing symptoms, (2) mediating disturbed patterns
of behavior, and (3) promoting positive personality growth and development.
Id. See also, JEROME FRANK, PH.D. & JULIA B. FRANK, M.D., PERSUASION AND HEALING
2 (The Johns Hopkins University Press 3d ed. 1991). Dr. Frank, one of the giants of the
field, described psychotherapy as a particular kind of influence:
Since practically all forms of personal influence may affect a person's
sense of well-being, the definition of psychotherapy is of necessity somewhat
arbitrary. We shall consider as psychotherapy only those types of influence
characterized by: 1) a healing agent, typically a person trained in a socially
sanctioned method of healing believed to be effective by the sufferer and by
at least some members of his or her social group. The healing agent need not
be a professional. Other types include a fellow sufferer, a group of fellow
sufferers with or without a trained leader, or even a book or audiotape
invested by the sufferer with healing powers. Except where specifically
indicated, the healing agents we shall consider are persons, 2) a sufferer who
seeks relief from the healer, 3) a healing relationship-that is, a circumscribed,
more or less structured series of contacts between the healer and the sufferer
in which the healer, often with the aid of a group, tries to bring about relief of
symptoms. This relief is typically accompanied by changes in emotional
state, attitudes, and behavior. Except in cases of involuntary treatment, all
concerned believe the changes to be beneficial. Although physical and
chemical adjuncts may be used, the healing influence is exercised primarily
by words, acts, and rituals in which sufferer, healer, and sometimes a group
participate jointly.
Id.
103. CAL. Bus. & PROF. CODE § 2903 (West 1990) ("Psychotherapy within the meaning
of this chapter means the use of psychological methods in a professional relationship to
assist a person or persons to acquire greater human effectiveness or to modify feelings,
conditions, attitudes and behavior which is emotionally, intellectually, or socially ineffectual
or maladjustive.").
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professional seeks to help those with mental disorders or mental health
problems through a process accomplished largely by the exchange of
verbal communication. 104
The term psychotherapy is ubiquitous in its application and covers so
much territory that it is difficult to exclude from its definition anything
involving a listener for a fee with the goal of improvement in one's life.
Trying to get accurate figures to describe the mental health enterprise is
most difficult because of the vagueness and ambiguity of the bread and
butter terms that define the basic activities of the mental health
profession.
Beyond the vagueness of the terms is another set of questions tied to
the issue of cost. Does psychotherapy do any good and can it do any
harm? Until recently the first question was simply and always assumed
to be "yes", at least by most of the public and most practitioners. As to
its potential harm, the historical record echoes with the sounds of
victims. 10 5 In truth, psychotherapy is a very potent tool both in terms of
helping to alleviate human distress and also in terms of causing great
human suffering.
Although managed care is no panacea (and in many cases has created
its own set of problems), 10 6 it has resulted in some positive change. It
has forced a spotlight on the practices of medicine and the mental health
enterprise. Those who have been impacted by managed care sneeringly
refer to its bottom line mentality and its sole focus on profit and loss.
Yet, its insistence on an economic analysis of cost and benefit has laid
bare the most glaring truth about the mental health enterprise. It has,
even more than medicine, remained nearly immune to the traditional
requirements of economic reality, of cost/benefit and the bottom line. 1
07
Before the growth of managed care, no one seriously required a
demonstration that treatment of mental health was actually effective.
Nor had there ever been scrutiny of its costs and whether its costs
reflected the best allocation of resources to deal with emotional
problems. Now these questions are unavoidable and the mental health
104. U.S. SURGEON GENERAL, MENTAL HEALTH: A REPORT OF THE SURGEON GENERAL 65
(1999) available at http://www.surgeongeneral.gov/library/mentalhealth/pdfs/C2.pdf.
105. See generally, ELLIOr-r S. VALENSTEIN, GREAT AND DESPERATE CURES (1986);
DINEEN, supra note 97; SINGER & LALICH, supra note 5; AYELLA, supra note 5.
106. HMO HELL, NEWSWEEK, Nov. 8, 1999, at 58; Christine Gorman, Playing the HMO
Game, TIME, July 13, 1998, at 22.
107. MILLER & MAGRUDER, supra note 6, at xvi ("Until recently, psychotherapy, like
much of medicine, remained relatively unconstrained by limits of time, data on outcomes,
financial expenditures, or by growing evidence of significant regional variation in practice
patterns unrelated to outcome.").
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profession is scrambling to come up with justifications for its
practices. 108
It is unfair to stereotype the response of the mental health profession
to this new reality. However, there has been far more energy and effort
devoted to attacking managed care than to coming to terms with the
glaring inadequacies in the mental health profession brought to light by
managed care. One article likened managed care and psychotherapy to
life under the Nazi regime, 109 another likened it to rape. 110 Long on
rhetoric and regret for the loss of power and autonomy, this type of
response is indicative of a profession suffering from one of its favorite
conditions-denial.
Denial may be understandable. The shift from a position of
unquestioned social eminence and power to one where that authority is
increasingly questioned and doubted has been a very rapid one. It is not
surprising that there has been a great deal of resistance to the new
demands for accountability and a displaced anger directed at the
messenger. But, the messenger can be demonized for only so long and
eventually, the same questions remain. What do you do? What does it
cost? Does it work? How does it compare cost wise with other modes
of treatment?"1
108. Id. at xv. Miller and Magruder wrote:
Psychotherapy is one of the predominant modes of mental health
treatment today, yet relatively little is known about how psychotherapy is
used, its cost, or its outcome, in "real world" settings. The absence of such
information, since the advent of health care reform efforts, has public health
officials, practitioners, researchers, and policymakers facing serious
questions regarding accountability-how well do these therapies achieve their
intended goals, and at what cost.
Id.
109. Karen Shore: Managed Care The Subjugation of a Profession, 14 PSYCHOTHERAPY
IN PRIVATE PRACTICE 2 (1995).
110. Ronald E. Fox, The Rape of Psychotherapy, 26 PROFESSIONAL PSYCHOLOGY:
RESEARCH & PRACTICE 2 (1995).
111. See Bob Dylan, The Times They Are a Changin', on THE TIMES THEY ARE A
CHANGIN' (Warner Bros., Inc. 1963). Dylan sang:
Come gather 'round people
Wherever you roam
And admit that the waters
Around you have grown
And accept it that soon.
You'll be drenched to the bone.
If your time to you
Is worth savin'
Then you better start swimmin'
Or you'll sink like a stone
Although sometimes lost in the hue and cry over managed care, the
concerns about the delivery of health care and mental health services in
general are profoundly important. If this article were written a decade
ago, the economic and social landscape would be very different. Ten
years ago the social mood involved budget deficits, unemployment, a
stagnating economy and a huge and expanding national debt."1 2 Today,
we have had a run of record prosperity with, at least for the foreseeable
future, record surpluses in state and federal hands. However, despite
the fact that the United States spends more on health care than any other
nation, our health care system ranks only thirty-seventh in the world
according to a report on the quality of health systems released June 21,
2000 by the World Health Organization." 3  Despite being awash in
MRIs, CT scanners and pricey drugs, the United States ranks in the
lowest twenty-five percent of industrialized countries when it comes to
infant mortality and life expectancy." 4 Despite the current budget
surplus, decisions about the allocation of resources are made from the
basis of scarcity. There are a finite amount of resources that can be
allocated to social problems. These problems compete for attention and
dollars. Managed care is simply one manifestation of a new and
powerful social and political force that is concerned with reducing costs,
increasing quality of service and broadening access to care. This new
focus has important and unavoidable implications for the practice of
psychotherapy.
Psychotherapy is not simply earnest discussions between a therapist
and a patient (or in the case of group therapy, between a therapist and a
selected group of patients). Nor is psychotherapy viewed as an end in
itself, a private and confidential discussion between a trusting and needy
patient and a wise and compassionate therapist. The grist of the
psychotherapy mill has ceased being private and confidential. It is now
only the preliminary part of a secular liturgy whose end point is in court
or the media. Psychotherapy not only focuses on the internal psychic
life of the patient. It now confers social status. Although harsh social
stigma still attaches to the label mental illness, it does not attach to those
who receive psychotherapy. Psychotherapy and in particular
psychoanalysis, always provided some cachet. It was the darling of the
For the times they are a-changin'.
Id.
112. Rosie Mestel, Despite Big Spending, U.S. Ranks 37th in Study of Global Health
Care, L.A. TIMES, June 21, 2000 at A20.
113. l
114.id-
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intelligencia who believed that one could not. be truly wise unless one
had been psychoanalyzed.
Today, psychotherapy confers status. It confers victim status on some
and perpetrator or abuser status on others. Conferring victim status
absolves some of responsibility for the patients' actions. Conferring
abuser status on others brands them evil and malevolent.
Today, psychotherapy creates collective narratives that have great
social impact. Psychotherapy now has an avowedly public aspect, most
typically confessional in nature. The fifty minute hour now involves the
requisite fifteen minutes of fame as psychotherapy patients confess
publicly to being perpetrators or victims of abuse.
This new facet of psychotherapy helps to define the public
consciousness about life in general. It helps create a shared social
consciousness by virtue of the values and beliefs held by the therapists
and the values, beliefs and actions of the patients. The products of
psychotherapy become part of larger social movements. They are
important, for example, in their impact on and interrelationship with
fundamentalist Christianity, the anti cult movement, the child protection
movement, and the survivor or recovery movement. As an example,
there remains a widespread "popular belief in the existence [and
operation] of an international conspiratorial satanic blood cult . . .
promoted primarily by public declarations of alleged cult survivors,
whose" public statements grew from psychotherapy and are then
legitimated by the psychotherapist. 11 5
To the extent that such social movements are the products of
irrationality and error, they have a great cost.1 16 The societal costs are
the ripple effect from their use. One such example involves the use of
Satanic Ritual Abuse Therapy in the criminal courts.
Satanic Ritual Abuse Therapy ("SRA Therapy") is a type of
psychotherapy built upon numerous questionable assumptions. It
assumes that there is a newly discovered type of crime ("Satanic Ritual
Abuse" or "SRA") heretofore cloaked in secrecy. It further assumes that
thousands of adults are the unknowing victims of SRA, troubled by a
variety of psychological problems but unaware of the root cause of the
problem due to severe physical, emotional or sexual abuse during
115. Sherrill Mulhem, Satanism And Psychotherapy: A Rumor In Search Of An
Inquisition, in The Satanism Scare 145-74 (James T. Richardson et al. eds., Aldine De
Gruyer 1991).
116. See Samuel Knapp & Leon VandeCreek, Risk Management For Psychologists:
Treating Patients Who Recover Memories Of Childhood Abuse, 27 PROFESSIONAL
PSYCHOLOGY: RESEARCH AND PRAcTICE 452-59 (Oct. 1996).
childhood.
SRA Therapy is based on the assumption that extreme traumatic
childhood events of abuse were repressed. Although there is no clear
definition of repression, the basic premise is that particularly shocking
events can trigger the mind to hide the memory away from conscious
awareness. 17  The theory then is that the presence of repressed
memories in the unconscious yields unpleasant psychological
symptoms. 18
Unpleasant psychological symptoms can only be relieved if the
individual can recover the traumatic memories and deal with them
consciously. By definition, survivors of SRA have repressed these
memories of the traumatic events and therefore are unaware. Thus,
psychotherapy is devoted to helping the individual recover the memories
through a variety of memory recovery techniques such as age
regression, guided imagery, sodium amytal, and hypnosis.
Common recollections from SRA Therapy include blood drinking,
ritual sexual acts involving children and human sacrifice both by others
and the individual "survivor."'1 19
Criminal prosecutors' use of SRA Therapy is well documented in
California. The most well known use has been by the Kern County
District Attorney's Office in Bakersfield, California. 2 ° In the 1980s and
early 1990s, a notorious series of criminal prosecutions took place all
involving a claim of an active satanic ring.12 Hundreds of people were
prosecuted and convicted of crimes using now discredited techniques
surrounding SRA theories. 122
The principal culprits in this exercise were the prosecutors' use of
117. Elizabeth F. Loftus, The Reality of Repressed Memories, 48 AM. PSYCHOLOGIST
518, 535 (May 1993).
118. Id
119. See generally, THE SATANISM SCARE (James T. Richardson et al. eds., 1991).
120. EDWARD HUMES, MEAN JUSTICE: A TOWNS TERROR, A PROSECUTOR'S POWER, A
BETRAYAL OF INNOCENCE 373-74 (1999) (documenting this unfortunate history).
121. Id
122. Id. Humes summarized the product of this sad chapter in Bakersfield's history as
follows:
With the release of the Kniffens and McCuans and Harold Weimer [in
1996 by an appellate court], the number of people freed from erroneous or
wrongful prosecutions in recent years in Bakersfield reached at least ninety
one .... The number is particularly extraordinary because the American
justice system is designed to make such reversals extremely difficult, with
laws that favor prosecutors over defendants at virtually every juncture once a
person is pronounced guilty.
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mental health professionals' testimony about the "evidence" derived
from the discredited techniques surrounding SRA Therapy. 23
How do you compute the cost of years of freedom stolen from several
hundred innocent men and women, who languished in prison for over a
decade, convicted with the help of mental health professionals relying
on a discredited psychotherapy technique? What is the social cost of
years of lives wasted and never to be reclaimed, relationships damaged
or destroyed, families torn asunder? Finally, what is the cost to the
integrity of a legal system that presides over such activities and allows
this type of testimony?
VI. THE GROWTH OF PSYCHOTHERAPY
The history of psychotherapy, particularly in the last forty years,
reflects the development of a multitude of new and emerging
psychotherapy techniques. Many of these techniques appear to lack
efficacy, and some do actual harm.
The mental health profession has a long history of exposing the
unsuspecting to the untested with disastrous results. From lobotomies
and insulin comas, to alien abduction therapy, satanic ritual abuse
therapy, facilitated communications, the sandtray and reparenting, the
profession continues to promote and use a variety of unproved and
potentially harmful psychotherapeutic techniques. It continues to allow
patients to be exposed to new and emerging therapeutic techniques
without validation of their efficacy or safety and without warning labels,
which are required as an ordinary component of the informed consent
process.
There are numerous examples of newly emerging therapeutic
techniques that have been introduced and used despite any showing of
efficacy. 124
123. Id. See generally, DEBBIE NATHAN & MICHAEL SNEDEKER, SATAN'S SILENCE
(1995).
124. SINGER & LALICH, supra note 5, at 3-4 (In 1995, Singer and Lalich inventoried
many, but not all, of the therapeutic techniques available today). They wrote:
The general public today is confronted with a panorama of theories and
practices said to address a variety of symptoms and disorders, ranging from
the supposedly scientific to the ludicrous and unchallenged. An array of
therapists, counselors, and healers promote the following techniques, among
others:
Flower essence therapy Hypnotherapy
Chakra and aura readings Angel therapy
Sexual touching Color therapy
Soul work Yoga
Although many critics attribute much of this to New Age beliefs, the
recent expressions of unproved psychotherapy techniques are simply
part of a long tradition in the mental health field. 
125
Humor therapy Past-life regression
Guided visualization Alchemy hypnotherapy
Karmic astrology Channeling
Alien-abduction therapy Herbal brews
White goddess healings Drumming
Crystal healings Intuitive readings
Dreamwork Breathwork
Mythmaking Vibrational bodywork
Trance treks Video work
Guided meditation Rapid eye technology
Tarot readings Overleaf charts
Aromatherapy Ritual ceremonies
Chemical inductions Shamanic counseling
(use of LSD, sodium amytal,
and other drugs)
Rebirthing Facilitated communications
Intuition Development Hot tubbing
Fighting Floating
Tours to sacred sites Depossession
These techniques-for which a consumer can pay anywhere from less than
one hundred to several thousand dollars-are purported to bring about results
such as the following:
Inner-child healing
Clear frequencies
Revelatory past-life journeys
Smooth life transitions
Parents' programming release
Alignment of fluid
Intelligence systems
Reclaiming your missing self
The body's energies rebalanced
Insightful shamanic journeys
Personal empowerment
Pain control
Planetary healing
Soul integration
Id. at 4-5.
Spirit releasement
Disharmonious energies release
Inner-child bonding
Spiritual healing
Inner purpose revealed
Becoming a galactic
Human being
Deep, transformative healing
Sexual karma revealed
Lifelong happiness
Transforming dragons
Soul retrieval
Past-life integration
Knowing essence twins.
125. VALENSTEIN, supra note 105, at 291-92. Valenstein reflects on the history of the
mental health profession (and medicine in general) as follows:
Although it may be comforting to believe that the forces responsible for
the wide acceptance of prefrontal lobotomy and the other somatic therapies
described in this book are all behind us, they are, in truth, part of the very
bone and marrow of the practice not only of psychiatry but of all medicine.
There are today no fewer desperate patients and desperate families;
premature reports of spectacular cures with minimal risks are still accepted
uncritically; the popular media promote innovative therapies even more
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To understand the limits of informed consent one need look no
further than the special defining characteristics of the population served
by medicine and psychotherapy. 26  That is the desperation,
demoralization and hopelessness of those afflicted with mental or
physical illness. The hopeless and the desperate, in particular, are prey
to the promoters of any new therapeutic enthusiasm. Informed consent
shrivels into a withered vine in the face of a therapist who confidently
says, "I have seen excellent results using this technique" or "I have a
great deal of clinical experience using this method." Personal
testimonials from self-interested therapists have the capacity to engage
and seduce the desperate and reduce informed consent to nothing more
than "fine print."
There are literally hundreds of different psychotherapeutic techniques
that are marketed and practiced today. These are not simply some
abstraction that appears in books and articles written for a self interested
few. These therapy techniques have immense impact on society and
individual lives both in terms of public and personal costs. Singer and
Lalich's list is far from exhaustive. 127 Many of these techniques have
arrived on the social landscape as public concern over the welfare of
children has grown. Facilitated communications, Satanic ritual abuse
therapy, and Sandtray therapy are a few of the many techniques.
There is a great deal written regarding each. However, there is
virtually no good research literature involving any of these techniques.
Regrettably, this is not unusual. It reflects one of the characteristics
unique to the mental health profession: Proof that something actually
works is not required. When research is done, it is like cotton candy,
tasty but without substance. The three techniques referenced above are
very representative of the development and use by the mental health
profession of a steady stream of supposedly innovative therapy
enthusiastically; economics is no less an influence on the selection of
treatment; conflicts persists within and between specialties; and ambitious
physicians still strive for "fame and name."
Id.
126. Frank, supra note 102, at 14. Frank wrote:
Patients ... typically seek or are brought to psychotherapy because they
have failed to fulfill others' expectations or their own. All experience
various degrees of helplessness, hopelessness, confusion, and subjective
incompetence. We propose to consider these and related feelings as
manifestations of demoralization, a term that denotes the psychological state
that responds to the elements shared by all psychotherapies.
Id. (alteration in original).
127. SINGER & LALICH, supra note 5, at 4-5.
approaches.
The Sandtray (or Sandplay) is simply a sandbox in a therapist's office
with various figures that a client is free to play with.'28 The types of
play engaged in by a client are treated as symbolic stories and
psychological realities that the client uses to communicate with
themselves and with the therapist.129 It grew from work done by a
British pediatrician, Margaret Lowenfeld, in the 1920s. 3' The original
theories were developed with reference to the thought and feeling world
of the emotionally developing child. It came to be known as Worldplay
or the Lowenfeld World Technique. 1
31
A Swiss Jungian analyst, Dora Kalff, began using this medium in her
work with children and adults. 132 "She called her work Sandplay
Therapy."' 133
The Sandtray is a projective technique. 134 It was nothing more than a
curious outgrowth of Jungian theory until it was embraced by the child
protection movement. Ultimately, the therapist places an interpretation
on this play which is an extremely powerful form of persuasion. The
only problem is, there is no sound empirical support for the scientific
128. BARBARA LABOVITZ BOIK & E. ANNA GOODWIN, SANDPLAY THERAPY 3 (2000).
129. Id.
130. Id. at 6.
131. Id
132. Gisela Schubach De Domenico, Ph.D., Sandtray World Play: A Psychotherapeutic
Technique For Individuals, Couples And Families, THE CAL. THERAPIST, Jan.-Feb. 1993, at
56, 56.
133. Id. De Dominico, a current practitioner, describes Kalff's work as follows:
For Kalff, sandtray therapy taps into the autonomous, (to the Ego
unconscious) healing force of the psyche (the Self), and promotes a
regression to the preverbal matrices of consciousness where the wounds of
inadequate mothering that resulted in the birth of a crippled and fragile ego
may be healed. Sandtray therapy was found to accelerate the verbal and
nonverbal workings of the Jungian analyses-the analysis and the sandtray
work were often kept separate.
Id.
134. GARY B. MELTON ET AL., PSYCHOLOGICAL EVALUATIONS FOR THE COURTS 45-46 (2d
ed., The Guilford Press 1997). "Mental health professionals have a [wide] array of
assessment [tests] and laboratory procedures" they use in diagnosing and treating patients.
Id. at 45. Projective tests are subjective and interpretational. "These tests do not rely on
self-reports of symptoms or experiences" of the patient. Id. "[T]hey require the [patient] to
view, interpret, and describe complex and ambiguous stimuli." Id. The Rorschach is the
most well known of the projective tests. The patient observes the stimuli (inkblots in the
case of the Rorschach) and projects his or her own perceptions onto the ambiguous stimuli.
Id. at 45-46. The theory behind the projective test is that a patient's interpretations reveal
something important about the way in which the patient views and understands the
environment. Id. at 46. A mental health professional then interprets the patient's responses
to aid in diagnosis and treatment. Id.
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validity of the interpretation other than the therapist's "clinical
experience" and the folklore surrounding the theoretical orientation of
Jungian Therapy.
SRA Therapy is a form of survivor therapy. 135 It is characterized by a
type of zeal fueled by very strange bedfellows.'36 It is part Christian
fundamentalism, part feminism, and part "save the children." It assumes
the existence of a vast conspiracy. 137
One problem with this picture is that, based on the available evidence,
it is illusory. Another problem is that there are people still in prison
who have been convicted of serious crimes on the basis of these
theories. The chief FBI investigator of this type of matter, Kenneth
Lanning, published a monograph for child abuse investigators in
1992.138 The monograph concluded, after more than 100 different
investigations by law enforcement into cases of alleged satanic cult
abuse, that no corroborative evidence was found.139  In 1994, an
exhaustive study by the Federal government lasting five years and
costing $750,000 determined that the rumor of satanic conspiracies was
unfounded and that there was no evidence of any organized incursions
into public day care. 140
Facilitated communications ("FC") is a technique used to help non-
verbal people with severe developmental disabilities to communicate. 141
135. Survivor therapy assumes that most everyone has "survived" some terrible scarring
from early childhood and that coming to terms with the trauma through therapy is necessary
for successful adjustment.
136. NATHAN & SNEDEKER, supra note 123, at 1.
137. Id. Nathan and Snedeker describe the movement as follows:
According to a claim that has been promoted for more than a decade by
preachers, police, prosecutors, psychotherapists, child protection workers,
and anti-pornography activists, there exists in this country-and indeed,
around the world-a massive conspiracy of secret Satanist cults that have
infiltrated everywhere into society, from the CIA to police stations to judges'
chambers and churches. The devil worshipers have even secreted themselves
in day-care centers and preschools, the story goes, where they pose as
teachers. This prospect has been particularly frightening, for it is said that
Satanists consider youngsters attractive prey for rape and torture and easy
recruits for their faith.
Id.
138. See generally, KENNETH V. LANNING, NATIONAL CENTER FOR THE ANALYSIS OF
VIOLENT CRIME, US DEP'T OF JUSTICE, INVESTIGATORS GUIDE To ALLEGATIONS OF "RITUAL"
CHILD ABUSE (Jan. 1992).
139. Id.
140. GAIL S. GOODMAN ET AL., CHARACTERISTICS AND SOURCES OF ALLEGATIONS OF
RITUALISTIC CHILD ABUSE (1994) (The final report to the National Center on Child Abuse
and Neglect).
141. SINGER& LALICH, supra note 5, at 176-78.
It involves "a 'facilitator' sitting beside a [subject] with the facilitator's
hand over the [subject's] hand." '142 "The [subject's] hand is then
facilitated to point to pictures, or words or to spell words, phrases, or
sentences, as the hand moves over [the keyboard]."' 43 "In this [fashion],
the facilitator 'assists' the nonverbal person to communicate."' 44 The
belief is that the presence and touch of the facilitator unlocks the
subject's ability to communicate and the selection of the keys or words
"is not influenced by the facilitator." 145
FC swept like wildfire throughout the United States beginning in
1989.146 It was embraced uncritically, not only in the developmental
disability community but also in the larger academic and treatment
community.' 47 It was miraculous in its apparent ability to allow words
to flow, expressing thoughts and feelings that had been locked up inside
the non-verbal developmentally disabled.
48 It was also a mirage. 49
Long after it had been promoted and accepted as a mainstream
therapeutic tool, the cruel harsh world of proof intruded. 50  Skeptics
asked for proof instead of testimonials. 5 There was no proof, only the
wishing and hoping of the desperate. 52  Double blind studies
determined that this technique did not work, but rather the facilitator
was communicating, often without conscious awareness, rather than the
subject. 53
A hoax perpetrated on the needy and vulnerable is shameful. But that
is only part of the picture. Parents were prosecuted and children were
removed from their homes as a result of messages facilitated that
claimed horrendous acts of sexual abuse had been perpetrated by mom
or dad or some other loved one. 154
142. Id. at 176.
143. Id. at 177.
144. Id
145. Id.
146. Id. at 178-79.
147. Id at 177-78.
148. Id at 177.
149. Id at 178-82.
150. Id
151. Id.
152. Id
153. Id. at 179-80.
154. Farai Chideya, The Language of Suspicion, L.A. TIMES MAG., Feb. 28, 1993, at 34.
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VII. INFORMED CONSENT AS A CONSUMER
. PROTECTION DEVICE
The doctrine of informed consent is increasingly being seen and used
as a consumer protection device. This is particularly so in the mental
health field where civil malpractice lawsuits, legislation, and regulatory
board actions seek to protect consumers from harmful psychotherapy
techniques.
The reach of such actions, even today, remains limited. 55 One of the
basic challenges is defining a standard of care with respect to
psychotherapy in general. Is there a standard of care with respect to
psychotherapy? Well, of course there is, but it is elusive.
The question has been addressed before. In a 1984 law review note,
the author identified the confusion and uncertainty behind the oft-stated
general rule. 156
The author identified the competing policy considerations that
impacted the standard of care as "the need to encourage innovative
psychotherapeutic techniques without denying patients their right to
receive responsible mental health care."' 157 The need to encourage and
foster innovation has been a staple of the defense or justification for
155. Telephone Interview with Tom O'Connor, Executive Officer of the California
Board of Psychology (Sept. 25, 1998 and June 22, 2000). In California, long recognized as
one of the most active and consumer oriented psychology boards, there has never been a
complaint received in which the charge against the psychologist was a failure to give
informed consent. Tom O'Connor confirmed this and observed that the Board complaint
tracking system does not even have a separate category for violations of informed consent.
O'Connor hasn't seen one, despite personally reviewing thousands of consumer complaints
over the last 11 years. Id. The odds of facing disciplinary charges for any reason are quite
small. Using California as an example, the number of charges filed against psychologists
remains very small compared to the approximately 16,000 psychologists in the state. In the
fiscal year 1998/1999 there were 520 complaints against psychologists received [by the
California Board of Psychology], 122 investigations opened, 40 formal accusations filed and
5 revocations of a psychologist's license. Id.
156. Lawrence P. Hampton, Note, Malpractice in Psychotherapy: Is There a Relevant
Standard of Care 35 Case W. Res. L. Rev. 251, 253 (1984). Hampton writes:
Courts have been hard-pressed ... to formulate a definitive standard of
care against which to measure the conduct of mental health professionals.
What passes as a legitimate form of therapy in one jurisdiction may be found
unacceptable in the next. Certainly one reason for the irresolution
surrounding the standard of care issue is the large number of different and
conflicting schools of therapy within the mental health profession itself. A
profusion of new forms of treatment merely exacerbates the problem.
Moreover, the very fact of change as a characteristic of psychotherapy would
appear to defy the notion of a definitive standard of care.
Id.
157. Id.
allowing mental health professionals to try new psychotherapeutic
approaches.' 58 This is so despite the fact that many of these approaches
can be described as nothing more than experimental.' 59 In medicine, a
new drug or device could not be marketed and used on patients unless a
rigorous process of controlled studies were conducted that established
that the drug or device was safe and effective. 6 ° The reasons are
obvious: Experience has established that drugs and medical devices can
and do harm and kill. The Hippocratic proscription "Primum non
nocere" (First, do no harm) compels a practitioner to treat using methods
that do not cause harm, but rather cure or relieve.' 61
There is no question that demanding proof of safety and efficacy
before the public is exposed to a new drug or device has saved countless
lives while fostering the development of many life saving medications
and devices. It has not prevented innovation or experimentation,
although the pace of discovery has been impacted by regulation. 1
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VIII. THE CONCEPTUAL LIMITS OF INFORMED CONSENT
The expectation that informed consent should act as a quality control
device to insure consumer protection is based on a misreading of the
basic purpose of the doctrine. The doctrine exists to further profoundly
important social interests in autonomy and self determination. 163 The
protection of consumers against exposure to unproved psychotherapy
techniques cannot be assured simply by the implementation of informed
consent.
The potential import of informed consent on individual lives and its
potential impact on the law and medicine is almost immeasurable. 164
158. ld.
159. See generally, JAMES HARVEY YOUNG, THE TOADSTOOL MILLIONAIRES: A SOCIAL
HISTORY OF PATENT MEDICINES IN AMERICA BEFORE FEDERAL REGULATION (1961)
[hereinafter YOUNG, TOADSTOOL MILLIONAIRES]; JAMES HARVEY YOUNG, PURE FOOD:
SECURING THE FEDERAL FOOD AND DRUGS ACT OF 1906 (1989) [hereinafter YOUNG, PURE
FOOD].
160. See generally, LAWRENCE M. FRIEDMAN ET AL., FUNDAMENTALS OF CLINICAL TRIALS
1 (3d ed., Springer-Verlag 1998) (1942).
161. Id.
162. No one can seriously dispute that the process of drug approval by the FDA is
lengthy and expensive.
163. CHARLES W. LIDZ et al., INFORMED CONSENT: A STUDY OF DECISION-MAKING IN
PSYCHIATRY 10 (1984).
164. Id. at 10-11. The authors write:
Informed consent reflects one of our highest social values, individual
autonomy. It reflects a strong emotional need for a sense of control over our
own lives and an admission of our dependence upon others, and it deals with
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But, in the vast literature on informed consent, there is nothing in it that
locates its source or its goal in what we have come to understand by the
term consumer protection. It is true that tort law recognizes the value of
the social good known as informed consent, but this is the only sense in
which the doctrine has an obvious linkage with consumer protection. In
fact, consumer protection is the by-product of the increasing
expectations from the "legal culture" Friedman described, brought to
bear on the delivery of medical care. Expectations rose on the tide of
the delivery of safe and effective medications, devices and treatments.
Modern medicine, through insistence on safety and efficacy, created a
systematic body of knowledge that was the cornerstone of consumer
protection. Consumer protection became a realistic and important
requirement only when the tools and methods existed within medicine
that could deliver on the promise.
IX. THE GOALS OF MEDICAL OR PSYCHOLOGICAL
INTERVENTION
Quality control and the delivery of safe and effective treatment are
core principles in medicine. These are assured by adherence to rigorous
testing under controlled conditions before a technique, procedure or
medication is recognized as safe and effective for use on the general
patient population.
Perhaps the most powerful and important advance in medicine in the
last century was the development and use of drugs to treat disease. This
development did not come without human victims, particularly before
creation of the Food and Drug Administration ("FDA").165 However, by
the century's end, the model used to develop new drugs came to provide
two crucial things, quality control and the delivery of treatments that are
safe and effective.
a subject of fundamental importance, our health ....
Informed consent is comprised of two legal duties imposed on physicians:
to inform patients about treatment, and to obtain their consent to treatment.
These duties are imposed in order to assure that a person's right of self-
determination may be maintained in one particular sphere of human activity,
the acquisition of medical care. In addition to safeguarding the right to
determine one's own destiny, the informed consent doctrine encourages, but
does not require, patients to make informed or intelligent decisions about
medical care.
Id. at 10 (citation omitted).
165. See generally, YOUNG, TOADSTOOL MILLIONAIRES, supra note 159; YOUNG, PURE
FOOD, supra note 159.
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The rigorous process by which drugs, devices or treatments are
evaluated in medicine is not of ancient vintage. In fact, even as late as
the mid-1940s, "most new medical treatments were introduced
informally[, generally by] a senior physician who had tried a new
treatment on a series of patients and obtained encouraging results."'
166
Today, the clinical trial is recognized as the definitive tool for the
evaluation of a drug, treatment, or device. "Only in the past few
decades [has] the clinical trial emerged as the preferred method for the
evaluation [of drug] or medical interventions." 167 "A properly planned
and executed clinical trial is a powerful experimental technique for
assessing the effectiveness of an intervention . . . . A clinical trial is
defined as a prospective study comparing the effect and value of
intervention(s) against a control in human beings."1 68
Before the advent of the clinical trial therapeutic, effectiveness was
judged on the basis of observation. 169  However, clinical observation
was a poor method by which to determine the utility of an
intervention. 170
166. EDWARD DOLNICK, MADNESS ON THE COUCH: BLAMING THE VICTIM IN THE HEYDAY
OF PSYCHOANALYSIS 288 (1998). Dolnick notes:
The more reliable, more cumbersome modern-day approach, which relies
instead on so-called randomized double blind controlled trials, is remarkably
recent. (The "double blinding" is an acknowledgment of the power of
positive thinking; in order to insure that no one's expectations somehow
muddle an experiment's results, neither patients nor physicians are allowed to
know which pills are real and which are placebos.) The first such trial in the
history of medicine did not take place until 1948, in Britain, when the
Medical Research Council tested the effect of streptomycin on tuberculosis.
Id. (citation omitted).
167. FRIEDMAN ET AL., supra note 160, at 1.
168. Id. at 2.
169. Id. at 6.
170. Id The authors continue:
A clinical trial is the clearest method of determining whether an
intervention has the postulated effect. Only seldom is a disease or condition
so completely characterized that people fully understand its natural history
and can say, from a knowledge of pertinent variables, what the subsequent
course of a group of patients will be. Even more rarely can a clinician predict
with certainty the outcome in individual patients. By outcome is meant not
simply that an individual will die, but when, and under what circumstances;
not simply that he will recover from a disease, but what complications of that
disease he will suffer; not simply that some biologic variable has changed,
but to what extent the change has occurred. Given the uncertain knowledge
about disease course and the usual large variations in biologic measures, it is
often difficult to say on the basis of uncontrolled clinical observation whether
a new treatment has made a difference to outcome, and if it has, what the
magnitude is. A clinical trial offers the possibility of such judgment because
there exists a control group-which ideally, is comparable to the intervention
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A clinical study, by definition, involves the use of intervention
techniques. 171 Central to the conduct of a modern clinical trial is the
notion of the control group. The control group is a group against which
the intervention group is compared. 172  At the outset of the trial it is
essential that the control group be sufficiently similar in relevant
respects to the intervention groups so that differences in outcome may
reasonably be attributed to the action of the intervention. 173
The ideal clinical trial is one that is randomized and double
blinded. 174  Randomization refers to the process by which participants
are chosen to be part of the clinical trial.175 Randomization is the
selection process in which each participant has the identical chance of
being assigned to either the intervention or the control group. 176
"Randomization tends to produce study groups [that are] comparable
with respect to known and unknown risk factors, removes bias in the
allocation of participants and guarantees that statistical tests will have
valid significance levels". 177
In the conduct of any clinical trial, bias is a primary concern; it is the
enemy of validity, it distorts and misleads, it can be caused by conscious
or unconscious factors or both, and it can occur at any point along the
path of the trial from initial design to data collection, analysis and
group in every way except for the intervention being studied.
Id.
171. Id.
172. Id.
173. Id. at 30.
174. id. at 61, 82.
175. Id. at 61.
176. Id.
177. Id. The authors further noted:
[R]andomization removes the potential of bias in the allocation of
participants to the intervention group or control group. Such allocation bias
could easily occur, and cannot be necessarily prevented, in the
nonrandomized concurrent or historical control study because the investigator
or the participant may influence the choice of intervention. This influence
can be conscious or subconscious and can be because of numerous factors,
including the prognosis of the participant. The direction of the allocation
bias may go either way and can easily invalidate the comparison.
The second advantage, somewhat related to the first, is that randomization
tends to produce comparable groups; that is, the measured and unknown
prognostic factors and other characteristics of the participants at the time of
randomization will be, on the average, evenly balanced between the
intervention and control group...
The third advantage of randomization is that the validity of statistical tests
of significance is guaranteed.
Id. at 43.
interpretation.178 The recognized solution is to keep the participant and
the investigator blinded as to the identity of the assigned intervention. 179
"In an unblinded or open trial, both the participant and the
investigator know which intervention the participant has been
assigned."' 8 °  Unblinded studies are easy to execute and therefore
inexpensive to conduct. 18  However, unblinded studies face the real
possibility of contamination by bias.182 "In a single-blind study, only
the investigators are aware of which intervention each participant is
receiving."' 83 It has most of the same advantages and disadvantages of
the unblinded trial.
184
"In a double-blind study, neither participants nor the investigators
[who follow] the participants knows the identity of the intervention
assignment." 185  Along with randomization, double blinding provides
the best method by which to eliminate the extraneous from the study
equation. 186
X. PSYCHOTHERAPY AND DRUGS AS FUNCTIONAL
ANALOGS
Psychotherapy, as a treatment for an emotional condition, is
analogous to a drug or medication prescribed to treat a medical
condition. Quality control and the protection of consumers from
exposure to harmful psychotherapeutic treatments can only be assured
by requiring that the mental health profession comply with the same
strict requirements that pharmaceutical companies must meet before a
drug can be marketed and used on patients.
178. I at 82.
179. Id.
180. Id.
181. Id.
182. Id at 83.
183. Id.
184. Id.
185. Id. at 85.
186. Id. The authors continued:
The main advantage of a truly double-blind study is that the risk of bias is
reduced. Preconceived ideas of the investigators will be less important,
because they will not know which intervention a particular participant is
receiving. Any effects of their actions, therefore, would theoretically occur
equally in the intervention and control groups. As discussed later, the
possibility of bias may never be completely eliminated. However, a well-
designed and properly run double-blind study can minimize bias.
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The problem occasioned by the absence of an FDA-like entity for the
testing of psychotherapy techniques has been recognized for many
decades. 187 Compounding the problem is the historical track record of
the mental health profession in scrupulously investigating its own
practices. 188
The term "drug" is defined in the Food, Drug and Cosmetic Act
("FD&C Act") as "articles intended for use in the diagnosis, cure,
mitigation, treatment, or prevention of disease in man" and "articles
(other than food) intended to affect the structure or any function of the
body of man." 189
This is a broad and inclusive definition. One would be hard pressed
to argue that psychotherapy is not identical in its operation. In order for
a drug to be recognized as such and marketed for use on patients, one
must demonstrate many things. First, one must show that the substance
or compound is biologically active. A substance that is biologically
active has a therapeutic effect that is greater than a placebo. Otherwise
it remains in the realm of sugar pills and saline injections.
Today, one may easily argue, based on rigorous empirically validated
studies, that some forms of psychotherapy are "psychologically active."
They do produce desirable effects that are quantifiable and are greater
than placebo. 190
187. SINGER AND LALICH, supra note 5, at 21. "[T]here is no equivalent of a Food and
Drug Administration to monitor therapies' or therapists' effectiveness. There is no
psychological FDA to root out unproved claims or dangerous practices." Id.
188. Id. Singer and Lalich state:
To society's loss, there is an alarming laxity within the mental health
professions when it comes to monitoring, commenting on, and educating the
public about what is good therapy, what is negligent behavior by trained
professionals, and what is or borders on quackery. Not enough attention is
paid to the conduct (whether illegal, damaging, or just plain crazy) of the
impaired therapist, the quirky therapist, the insufficiently trained therapist.
We open the daily paper and see advice about which movies are good,
which books are helpful, which food products are healthful, but we find no
objective guides for evaluating the efficacy of a particular treatment.
Id.
189. 21 U.S.C. § 321(g)(1)(B)-(C) (1994).
190. See KENNETH I. HOWARD et al., The Cost-Effectiveness of Psychotherapy: Dose-
Response and Phase Models, in COST-EFFECTIVENESS OF PSYCHOTHERAPY: A GUIDE FOR
PRACTITIONERS, RESEARCHERS AND POLICYMAKERS 143, 143 (Nancy E. Miller & Kathryn M.
Magruder eds., 1999) (The efficacies of specific psychotherapies have been established in
numerous controlled studies). Howard et al. wrote:
Psychotherapy works. The evidence supporting this conclusion has
accumulated from many sources and research designs. Whether one
examines the retrospective survey responses of psychotherapy consumers, or
the results of many clinical trials, the verdict is that psychotherapy is
Drug therapy and psychotherapy are both interventions designed for
similar purposes: to reduce symptoms of physical or emotional distress
and, where possible, resolve or cure disease.19' There are various ways
to measure therapeutic outcomes; however, in both drug and
psychotherapy research, the most basic method is to observe and
document the change in the number and severity of specific symptoms
of a disease or disorder. 192  Interestingly, rigorous research of
psychotherapy is now attempting to evaluate a particular therapeutic
technique, not only on the basis of short-term reduction of symptoms,
but also on longer-term functional and economic measures of general
health, work, consumer preference, and subjective quality of life
decisions. 193
Drugs and psychotherapy are functional analogs on all relevant
domains. It has long been a central focus of investigational drug studies
to develop data regarding dose response. Dose response is the
"[c]orrespondence between the amount of an administered drug and the
magnitude of the evoked reaction. ' ' 194 Psychotherapy researchers have
now developed sophisticated measures to assess the dose response of
specific psychotherapeutic interventions. 195 Having solid information
on the dose response rate is crucial to any health care provider, whether
medical or mental. 196
Drugs and psychotherapy share a common domain involving toxicity
and adverse reactions. The evaluation of drug toxicity and adverse
reactions is central to the process by which the FDA approves the use of
a new drug. It involves two questions: (1) does the drug make the
condition worse, or (2) does it have damaging effect on other body
systems? One may obtain this type of data through psychotherapy
outcome research. Equally applicable to drugs and psychotherapy is the
generally efficacious.
Id. (citations omitted).
191. Id. at 144-46.
192. Id. at 143-44.
193. Id. at 146-47.
194. THE MERCK MANUAL OF DIAGNOSIS AND THERAPY 2573 (Mark H. Beers, M.D. et al.
eds., 17th ed. 1999). Dose response is the correspondence between the amount of an
administered drug and the magnitude of the reaction evoked. Id.
195. See MILLER & MAGRUDER, supra note 6, at xxii. ("Although 'dosing' is typically
thought of in relationship to pharmacotherapy, the concept is equally valid for
psychotherapy.").
196. Id. at xxi. ("Such monitoring of interim responsiveness is essential in the real world
so that clinicians know when to take correctional action such as modifying the dose,
augmenting with adjunct treatment, changing the treatment entirely, or reassessing the
diagnosis.")
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domain of benefit-to-risk ratio. 197
There is no question that certain types of psychotherapy used on
certain types of patients create harm. Suicides and extreme dependence
are two of the most obvious harms, but the history of psychotherapy in
the last century is filled with other examples.198 In fact, just as certain
drugs have the potential for addiction and dependence, so does
psychotherapy. One of the classic indicators of some forms of
psychotherapy is the tremendous dependence created intentionally by
the therapist. 199
Despite the fact that drugs and psychotherapy are functional analogs,
there are some dissimilarities which are important to recognize. One of
the fundamental differences is that for most medical interventions,
informed consent relates to a discrete event, whether a surgery or a
diagnostic test like an angiogram or an EKG. Psychotherapy is far more
a process than an event, and it can last weeks, months or even years.
Also, the course of psychotherapy can lead to changes in focus or
approach, as some problems are addressed and others appear. In that
sense, informed consent must be revisited during the process of
psychotherapy.200
Another basic difference involves the less focused goals of
psychotherapy intervention. In medicine, a drug targets a specific
disease entity. The goal of the drug intervention can be judged by fairly
197. MERCK MANUAL, supra note 194, at 2592. The Manual notes:
For each clinical situation and patient, risks must be weighed against
benefits by considering the qualitative and quantitative effects of using a drug
and the likely outcome if the drug is withheld. Drug therapy is justified only
if the possible benefits outweigh risks. The decision depends on adequate
knowledge of the patient, of the disease and its natural history, and of the
drug and its potential adverse effects.
Id.
198. See generally DOLNICK, supra note 166 (describing the historical approach of
psychoanalysis treatment of schizophrenia, autism, and obsessive-compulsive disorders).
199. KENNETH S. POPE & MELBA J.T. VASQUEZ, ETHICS IN PSYCHOTHERAPY AND
COUNSELING: A PRACTICAL GUIDE FOR PSYCHOLOGISTS 35-41 (Jossey-Bass Inc. 1991).
200. Id. at 75. The authors note:
[I]nformed consent tends to be a recurrent process. The patient may
consent to an initial psychological, neuropsychological, and medical
assessment as well as to a course of individual psychotherapy based upon an
initial, very provisional treatment plan. Several months into treatment, the
treatment plan may be significantly altered on the basis of the results of the
assessments, the patient's diverse reactions to various components of the
treatment plan, and the patient's changing needs. As the treatment plan
undergoes significant evolution, the patient must adequately understand these
changes and voluntarily agree to them.
objective criteria. For example, the efficacy of an antibiotic used to treat
a particular type of bacterial infection can be judged by reference to
changes in a blood chemistry panel or a patient's temperature.
The field of psychotherapy, by contrast, has been characterized by a
lack of focus or agreement on what the goal of psychotherapy
intervention is. There has been a tremendous expansion of the purposes
or goals of psychotherapy. Although many of the great names in the
history of psychotherapy have referred, for example, to individual self-
fulfillment or autonomy and creativity as goals of psychotherapy, there
has not been much agreement about what range of problems pertaining
to individual self-fulfillment should be included within the boundaries
of mental health care.
The historically unfocused goals of psychotherapy intervention have
changed recently primarily due to the pressures from managed care.
Thus, treatment aims have become much more clearly defined due to the
development of targeted, time limited interventions, many of which are
empirically based. 20 1
Although there are some differences in drugs and psychotherapy, they
both are amenable to research and study using the same tools. The
problem isn't that it is impossible to conduct randomized controlled
clinical trials of specific psychotherapy interventions that would lead to
empirically validated treatments. This has already been done with
respect to some modes of psychotherapy intervention on certain
psychiatric disorders. The problem is that the clinicians in the real
world of psychotherapy practice have tended to ignore the research
literature. 202
Efficacy and safety of various psychotherapy interventions have
already been demonstrated in controlled clinical trials.203 Unfortunately,
201. Docherty, supra note 94, at 6.
202. Steven D. Hollon, Psychotherapy and Pharnacotherapy: Efficacy, Generalizability,
and Cost-Effectiveness, in COST-EFFECTIVENESS OF PSYCHOTHERAPY: A GUIDE FOR
PRACTITIONERS, RESEARCHERS AND POLICYMAKERS 14, 17 (Nancy E. Miller & Kathryn M.
Magruder eds., 1999). Hollon continues:
Surveys find that practicing clinicians pay little heed to the controlled
empirical literature and rely more on an informal network of case reports,
workshops, and collegial interactions to inform their clinical practice. One of
the most widely voiced complaints of practicing clinicians over the years has
been that psychotherapy research is of minimal relevance to them.
Id. (citations omitted).
203. Id. at 15. Hollon further notes:
The newly developed cognitive behavioral therapies (CBTs) and
interpersonal psychotherapies (IPTs) appear to be at least as effective as
medications in the reduction of acute distress in mildly to moderately
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there have been very few efforts to determine efficacy of most
traditional talk-based psychotherapies. These are the ones that are most
widely practiced in applied treatment settings. The fact that there is
such an absence of empirical support does not mean that these
traditional modes of talk therapy are ineffective. Absence of empirical
support does not necessarily equate to absence of efficacy. It does,
however, equate to an absence of knowledge about important matters
involving public safety as well as cost.
Although most practitioners are unaware of the research literature on
efficacy, there are strong pressures to evaluate all methods of
psychotherapy. Furthermore, because there is such a heightened
emphasis on cost effectiveness, there is a growing interest in assessing
the differential benefits of drugs and psychotherapy relative to their
costs. The logic of this effort is compelling. If two treatments produce
comparable outcomes, the less expensive alternative (either in terms of
dollar costs or freedom from undesirable complications) is likely to be
preferred. 204
The challenge to establish efficacy and safety of discrete
psychotherapy interventions targeted to specific psychosocial problems
is not one of feasibility. The problem involves making a commitment to
develop empirically based knowledge and following that knowledge in
the direction it leads. Interestingly, much of the good research already
done on various psychotherapy interventions has been done by or with
the assistance of the National Institute of Mental Health (NIMH). 205
Quality control and consumer protection are not the natural by-
products of informed consent in medicine or in the mental health field.
They are the natural by-products, in medicine, of a system of evaluation
that is rigorous and empirically driven, that forces the proponent of a
new drug or device to establish that the drug or device is safe and
effective for use on patients. The FDA model is an imperfect one, but
even a cursory history of the last century shows that the promotion of
rational drug design overseen by the FDA has led to astonishing
depressed outpatients and may enhance the breadth and stability of response
relative to pharmacotherapy alone among even more severely depressed
patients. Exposure-based therapies have been shown to be quite helpful in
reducing compulsive rituals in obsessive-compulsive disorder and behavioral
avoidance in severe agoraphobia and are often combined with medications.
CBT appears to be at least as effective and possibly longer-lasting than
pharmacotherapy in the treatment of panic disorder and social phobia.
Id. (citations omitted).
204. Id. at 19-20.
205. Id.
pharmacotherapy breakthroughs with a minimum of harm to the public.
Today, the pharmaceutical industry is developing drugs through its
design methods that are more effective than ever with fewer side effects.
Quality control and consumer protection can be, however, the natural
by-products of such a system of evaluation and testing of psychotherapy
techniques using the model of the FDA. Consumers are entitled to
nothing less. They go to a psychotherapist expecting that they will
receive a treatment that has a sound basis for use on them. If it does not,
then it is an experiment and a patient is entitled to be informed of that
fact. The sound basis, for most patients, is a basis created by reference
to the available science. Otherwise, they would choose the company of
astrologers or mystics.
XI. THE PRACTICAL LIMITS OF INFORMED CONSENT
Even when its conceptual limits are acknowledged, informed consent
has had limited impact on the mental health profession. Despite decades
of commentary on its important role, it is reflected more in its breach
than its observance. In this regard, it shares much in common with the
inadequacies of the doctrine in medicine. Furthermore, despite decades
of intense debate and emphasis on informed consent in medicine and in
the mental health profession, its promise remains unrealized.
Although its relative influence continues to be debated, there is no
question that informed consent today occupies a central place in the
relationship between physician and patient.
The doctrine of informed consent is a paradox. Despite decades of
talk, writing, case law and legislation, informed consent remains long on
words and short on results. 20 6
Informed consent has been problematic for health care professionals
on multiple levels for as long as it has been debated by clinicians and
scholars. In 1980, one of the early studies was done questioning
206. WEAR, supra note 3. Wear captures this paradox perfectly in his 1998 book. Wear
is a professor in the Departments of Medicine and Philosophy and Co-Director of the Center
for Clinical Ethics and Humanities in Health Care at the State University of New York at
Buffalo. His assessment of informed consent as it is currently operant in medicine is:
[T]hat the doctrine of informed consent, as currently articulated in the law
and the bioethics literature, suffers from a substantial ritualistic and rhetorical
character that both lessens its effectiveness and makes it presume to provide
benefits that it often fails to accomplish. In large part, this is so because this
doctrine remains uncalibrated to the realities and variables within clinical
medicine.
Id. at 5.
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whether cancer patients could recall receiving informed consent
information. "Within one day of signing consent forms for
chemotherapy, radiation therapy or surgery, 200 patients completed a
test of their recall of the material in the consent explanation and filled
out a questionnaire regarding their opinions of its purpose, content, and
implications. '20 7  The conclusions the authors drew about the
ineffectiveness of informed consent are sobering, but not inconsistent
with the overwhelming weight of other scholarship, both before and
after.208
207. Barrie Cassileth et al., Informed Consent: Why are its Goals Imperfectly Realized?,
302 NEW ENG. J. MED. 896, 896 (1980). Cassileth et al. explained:
Informed consent has remained a focus of intense interest since the
Nuremberg Code was adopted in 1947. Attention has centered on two
general aspects of informed consent: its legal and ethical ramifications, and
its practical effectiveness in the clinical setting. This study is concerned with
the latter.
The goal of the consent process is to provide a mechanism for patients to
participate in treatment decisions with full understanding of the factors
relevant to their proposed care. However, previous studies have shown that
patients remain inadequately informed, even when extraordinary efforts are
made to provide complete information and to ensure their understanding.
This appears to be true regardless of the amount of information delivered, the
manner in which it is presented, or the type of medical procedure involved.
Id. (citations omitted).
208. Id at 899. Cassileth et al. concluded:
The results of this study corroborate previous work indicating that many
patients fail to recall major portions of information on consent. The relation
between educational background and patient's ability to describe the
information, together with the similar correlation between education and the
care with which patients read consent forms, suggests that such
communications are too complex and difficult for many patients to grasp,
despite the fact that most patients reported understanding all or most of the
information.
Bedridden patients were less able to recall this information than were
patients in better physical condition. As patients become increasingly ill,
their sense of personal control over their own destinies may give way to
intensified dependence on their physicians, and this dependence may result in
poorer attention to, interest in, and recall of information about consent.
Intellectual as well as physical deterioration may have had a role in poorer
recall, although the patients studied were competent enough to sign consent
documents and participate in this research.
... The consent form's legalistic, perhaps even adversarial, overtones
may appear inconsistent to the patient who has a fundamental orientation to
and preference for a doctor-patient relation based on 'trust.'
The purpose of the consent procedure, to facilitate and ensure informed
decisions on the part of the patient, is poorly accomplished and may actually
be thwarted by the present procedure. Barriers are imposed by the difficulty
of the material and by the legalistic and other negative connotations of the
consent documents. These barriers need to be removed if consent forms are
to achieve their intended objectives and if patients are to function as the
In a companion article, five surgical consent forms were evaluated
and analyzed with two standard readability tests. 20 9 The study found
that "[t]he readability of all five surgical forms was approximately
equivalent to that of material intended for upper-division undergraduates
or graduate students. Four of the five forms were written at the level of
a scientific journal, and the fifth at the level of a specialized academic
magazine. 210
Not much has changed, apparently, in the ensuing twenty years. In a
study reported in the Journal of The American Medical Association
(JAMA) in December 1999, researches analyzed doctor-patient
interactions in routine office visit situations to determine if patients were
given enough information to make a truly informed consent. The
researchers analyzed 1,057 audiotaped encounters between primary care
doctors and surgeons and their patients. The cases involved decisions
such as whether to have a lab test to check thyroid hormone level and
whether to have laboratory prostate-cancer screening. Most troubling of
all the findings is this: something important was missing from
discussions ninety-one percent of the time.
211
informed consumers that many of them wish to become.
Id. at 899-900 (citations omitted).
209. T.M. Grundner, Ed.D., On The Readability Of Surgical Consent Forms, 302 NEW
ENG. J. MED. 900, 900 (1980).
210. Id Grunder explained:
These forms are by no means to be considered anomalies. They were
selected from a wide variety of hospitals serving a wide variety of people. It
is likely that if every surgical consent form in the country were subjected to
similar analysis, few would pass.
... Yet we might well speculate that this situation is exactly what occurs
in hundreds of hospitals around the country every day. Literally tens of
thousands of people may be undergoing surgery on the basis of an ethically
inadequate consent.
Id. at 901-02.
211. Clarence H. Braddock, et al. Informed Decisionmaking In Outpatient Practice: Time
to Get Back to Basics, 282 JAMA 2313, 2313 (1999). The researchers concluded:
In this study, we set out to determine the completeness with which
physicians involved patients in routine, but important, clinical decisions in
office practice. We analyzed these discussions with criteria that sought to
balance an ethical ideal with practical reality by taking into account
important differences in decision complexity. We found that surgeons and
primary care physicians in office practice infrequently had complete
discussions of clinical decisions with their patients.
These findings suggest that the ethical model of informed decision
making is not routinely applied in office practice. The low level of informed
decision making suggests that physicians' typical practice is out of step with
ethical ideals. There are practical implications of this missing practice.
Inadequate efforts to foster patient involvement in decision making may
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The studies cited above are representative of a vast literature that
consistently shows the absence of informed consent in doctor-patient
encounters. 2
12
The literature about informed consent in the mental health professions
is not as robust during the same period but has been and continues to be
extensive. Mental health professionals have been told about their ethical
and professional obligations to provide informed consent repeatedly in a
variety of contexts.
An article in the September 1989 issue of The California Psychologist
by Muriel Golub, Ph.D. is typical of the professional writing, although it
is a more sophisticated and nuanced explication than some. Entitled
Informed Consent and the Establishment of Therapeutic Sanctuary, it
provides a well-delineated roadmap for a psychotherapy practitioner
along with a well-reasoned analysis of the intrinsic value of the
informed consent process. 213
Golub identifies the often mistaken and unrealistic expectations of a
impair the patient-physician relationship. Furthermore, there are quality-of-
care concerns, since there is mounting evidence that inadequate patient
involvement may interfere with patient acceptance of treatment and
adherence with medical regimens.
For too long, informed consent in clinical practice has been influenced by
an interpretation of informed decision making as a legal obligation in which
the emphasis is full disclosure, rather than an ethical obligation toward
mutual decision making by fostering understanding. Furthermore, most
emphasis has been on informed consent for invasive procedures or
participation as a research subject. Turning attention to decision making in
office practice reveals that this emphasis has not created a positive model of
informed decision making that is relevant and achievable in clinical practice
in which the majority of decisions are less than complex. Promotion of the
patient's understanding, thereby fostering informed participation, is the
essence of informed decision making.
Id. at 2318-20 (citation omitted).
212. WEAR, supra note 3, at 35. ("[T]he empirical data and common clinical experience
strongly suggest that many patients take little or no interest in informed consent and do not
readily embrace the authority and responsibility it seeks to provide.").
213. Muriel Golub, Ph.D., Informed Consent and the Establishment of Therapeutic
Sanctuary, 23 THE CALIFORNIA PSYCHOLOGIST 19 (1989). Golub notes:
It is the job of the psychotherapist to aid in the establishment of a
therapeutic sanctuary, a place of safety and trust within which the work of
psychotherapy can be done by the patient. The foundation for this sanctuary
is laid in the first few sessions. A comprehensive process of informed
consent leads to the development of the therapeutic alliance, aiding in the
patient's acquisition of knowledge of the structure and process of
psychotherapy as well as an awareness of the possible risks to be
encountered.
new patient as a necessary subject for discussion. Informed consent
must dispel these erroneous expectations.
214
Golub also identifies the need for disclosure of information about the
therapist himself, including the need "to know about the boundaries of
the therapist's competence, as well as the therapists' training and
professional orientation.
215
While discussing the nuts and bolts of what informed consent is,
Golub also suggests that informed consent is far more than an ancillary
intake exercise largely unrelated to the goals of psychotherapy. It can
and should be a way of establishing the framework within which the
work of psychotherapy takes place.
216
Practitioners are reminded of their duty to provide an informed
consent by their own state regulatory boards 217 as well as in publications
of a quasi-official nature such as the Register Report218 of the National
Register of Health Service Providers in Psychology.21 9 Mental health
professionals encounter a consistent message about informed consent
214. Id "It is the therapist's responsibility to advise the patient about the process itself
(what it is like, what to expect, what not to expect), as well as to advise about the positive
and negative consequences that may come about through participation in psychotherapy."
Id.
215. Id.
216. Id. Golub continues:
This process is made possible by the development of trust and safety, and
a feeling of confidence in the therapist and in the process itself. Informed
consent helps construct the foundation of trust and safety, and represents one
very positive example of combining ethical integrity with basic good
therapeutic practice.
Id.
217. The California Board of Psychology, for example, publishes and distributes the BOP
Update, a free periodical sent to all licensees. A January, 1997 issue featured an article by
the Chairperson of the board on Informed Consent. See Bruce Ebert, PhD, JD, Informed
Consent, BOP UPDATE, Jan. 1997, available at http://www.psychboard.ca.gov/ (last visited
Aug. 20, 2002). Ebert's article detailed the history of the development of the doctrine and
specifically identified ten items that a client should be informed of and concluded: "The
BOP finds psychologists have a legal, ethical and clinical obligation to obtain proper
informed consent from clients. Procedures to establish informed consent should be
implemented immediately in your practice." Id.
218. Jeffrey N. Younggren, Ph.D., Informed Consent: Simply a Reminder, 21 REG. REP. 6
(1995).
219. The National Register of Health Service Providers in Psychology, established in
1974, is the largest credentialing organization for psychologists in health care service
delivery. Its primary goal is to contribute to the improvement of health services to the public
through developing standards for evaluation of the credentials of psychologists, reviewing
such credentials, disseminating information on credentials, evaluating educational programs,
preparing publications, conducting ethics programs. It publishes the Register Report, the
Newsletter of the organization, and distributes it to members and others who subscribe to it.
See http://www.nationalregister.com/.
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from the texts and practice guides on ethical practice in the mental
health field. 220
XII. THE FAILURE OF SELF-REGULATION
The history of the mental health profession in the century just passed
demonstrates that it is a profession incapable of regulating itself in any
meaningful way. Innovation and creativity have become ends in
themselves. Questionable psychotherapeutic techniques continue to
flourish in the face of mounting evidence that they are ineffective and
often harmful. Rather than cleaning its own house, the mental health
profession has responded by using its time worn arguments that only it
can know and understand the intricacies of the human mind and
regulation and external oversight will hamper the innovation necessary
to conquer the ills of the human mind.
More than anything, what has characterized the mental health
enterprise in the last half century has been a focus on innovation and
expanding the sphere of influence of the profession.221 New techniques
and grand theories were embraced and breakthroughs were confidently
reported typically long before there was any demonstration of efficacy.
The end product has time and again been social mischief and patient
harm.
The cultural history of autism is today a little remembered and, for the
mental health profession, a conveniently ignored dark secret. An in
depth history is beyond the scope of this work,222 but a condensed
version does give clear insight into the deference that has been
traditionally accorded to the "doctors of the mind" despite the lack of
any compelling evidence that would demonstrate that their
pronouncements were anything more than speculation on a grandiose
scale.
Autism is recognized today as a disorder neurological in origin,
although a definitive etiology remains elusive and to be determined. It
was first recognized as a discrete clinical and diagnostic entity in 1943
when an Austrian born psychiatrist, Leo Kanner, identified a condition
in children so peculiar that he felt it deserved further study. He labeled
the condition "autism," Greek for "self," because of the children's
220. See, e.g., GERALD P. KOocHER & PATRICIA KEITH-SPIEGEL, ETHICS IN PSYCHOLOGY:
PROFESSIONAL STANDARDS AND CASES (2d ed., Oxford University Press 1998).
221. Docherty, supra note 94, at 5.
222. DOLNICK, supra note 166.
seeming lack of any interest in other people.223 Bettelheim noted these
same qualities in some of the disturbed children he was treating, and
soon this condition became the focus of blame for parents of these
distressed children, as they were dubbed schizophrenogenic mothers.
224
What Bettelheim and others managed to do is stigmatize and
traumatize generations of parents, mostly mothers, blaming their poor
parenting as the cause of this horrific disease that afflicted their
children. 225  The enthusiasm with which the theory of the
schizophrenogenic mother was embraced and promoted is today nothing
more than an embarrassing footnote to history, but it is not unique, nor
have its lessons been learned by the profession.226 What stands out
today, looking back, is the utter lack of science, the total disregard of the
scientific method and abandonment of the healthy skepticism that is the
sine qua non of good scientific investigation. That this bogus and wrong
collection of theories had such powerful social currency and power
tracks an eerie parallel with the history of lobotomy, 227 and today with
the wildly unsupported theories surrounding recovered memory therapy.
Dolnick asks the question, why didn't the psychoanalysts know any
better in the 40's, 50's and 60's when they were confidently blaming
mothers and parents in general for the autism of their children? The
answer is that psychoanalysts were unconcerned with the rigorous
demands of statistics or control groups and far more comfortable relying
on anecdote and case study.
228
223. Id. at 171.
224. Id. at 187-88, 190-92, 193.
225 See generally THE SOCIAL PSYCHOLOGY OF STIGMA (Todd F. Heatherton et al. eds.,
2000) (discussing various topics of importance to the social psychological understanding of
stigma).
226. DOLNICK, supra note 166, at 294. As Dolnick concludes his book:
There is a tendency in the human heart, or brain, to find meaning where
there is only happenstance. Worse, there is a tendency to assign blame where
there is only bad fortune. The psychoanalysts gave in to this perennial
temptation. In doing so, they caused long-lasting, needless harm to those
already bowed low by fate. Unable to acknowledge the wisdom of Robert
Frost's definition of a tragedy-"something terrible happens and nobody is to
blame"-they blamed the victim of illness for the misfortune that had befallen
them.
Id.
227. VALENSTEIN, supra note 105.
228. DOLNICK, supra note 166, at 286-87. "Beyond hubris, beyond ideological zealotry,
beyond the shutting out of outside voices, two factors played key roles. The first had to do
with medicine, the second with science." Id. at 286. Dolnick noted:
The reliance on anecdotes was the most important example of this non-
rigorous approach. Psychoanalysts seldom bothered with controls and
steered away from statistics, partly out of distaste, partly in recognition of
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As we view the last century of the development of the mental health
profession, it is an unavoidable conclusion that the era of laissez faire,
of deference to self-entitled expertise and the need to promote
innovation, have led not only to important insights and advances, but
also to grand and catastrophic mistakes that caused great and lasting
harm to patients and society as well. 229 The mistakes and errors apply to
both psychology and psychiatry. 230
The mental health enterprise faces an uncertain future as it embarks
on the stormy seas of the twenty-first century. It faces serious
challenges and critique both from inside and outside the profession. No
evolving and dynamic academic or scientific discipline is free of
controversy or immune from criticism. However, the challenges and
genuine difficulties, and partly out of a humane impulse to focus on patients
rather than on abstractions. Instead, they placed enormous weight on
anecdotes and case histories. On the basis of six or ten or twenty cases, they
laid down sweeping generalizations about diseases that affected thousands or
millions.
Id. at 287.
229. RICHARD OFSHE & ETHAN WATTERS, MAKING MONSTERS: FALSE MEMORIES,
PSYCHOTHERAPY AND SEXUAL HYSTERIA 8-9 (1994). In the following quote, Ofshe and
Waters are writing about recovered memory therapists but the comment has universal
applicability to the mental health profession:
The fact that recovered memory therapists could so damage their patients
and yet, until recently, largely escape criticism illustrates how incapable the
mental health profession is of evaluating and curbing fad treatments that
grow within its ranks. While mental health professionals look with horror at
the seemingly barbaric mistakes of their predecessors, each generation
appears unable to stop the birth of new damaging practices.
Id.
230. Paul R. McHugh, Witches, Multiple Personalities, and Other Psychiatric Artifacts, 1
NATURE MED., Feb. 1995, at 110. McHugh wrote:
Psychiatry is a medical discipline long on disorders and short on
explanations ....
However, this shortage of agreed-upon explanations brings good news
and bad news. The good news is there is plenty of room for useful scientific
research in psychiatry and a great deal of this is going on at this moment.
The bad news is, because practitioners in this discipline are hungry for
explanations today, at least once each decade, psychiatry is swept by an
enthusiasm for a fundamentally incoherent practice, and then must spend at
least ten years subsequently digging out of the troubles that this practice
produced. These misdirections of psychiatry rest squarely on standard
medical mistakes such as oversimplification, misplaced emphasis or pure
invention. The enthusiasms for these misdirections, however, usually derive
from an uncritical acceptance of transient cultural attitudes and fashionable
ideas. The repeated combination of these elements proves how all too often
the discipline of psychiatry has been the captive of culture, to the detriment
of everyone.
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assaults on the mental health enterprise are unprecedented in their scope
and force.
It is easier to dismiss the challenges from the outside. Perhaps
outsiders don't understand. Maybe outsiders fail to see the big picture,
or outsiders just have an axe to grind. The critiques from inside are
another matter. These are hard to explain away and increasingly
difficult to answer.
Collectively, these voices are calling into question the core practices
of the mental health profession in practicing psychotherapy and in the
expression of professional opinion.231  The questions they ask are
simple. What is the justification (evidence of efficacy and safety) for
what you do with your patients/clients? What is the empirical support
for the things that you do and the opinions you express? The truth is
that there is scant empirical scientific support for much of what the
mental health profession does. Heretofore, no one has really demanded
it. One is forced to ask the question how can this be if a psychotherapist
is required by law and the practice codes of the profession to give a
patient/client an informed consent before instituting treatment?
Now, the mental health profession is being asked to justify its actions.
The new economics of the marketplace (managed care) and the new
legal landscape 232 are unfriendly, unwelcome visitors in the waiting
rooms of today's therapists.
The response from the profession is reminiscent of a multiple
personality. A segment of the profession responds by acknowledging
the real limits of the profession and seeks empirical data to support or
refute their practices. Another very large segment is in denial. That is,
a refusal or inability to recognize the facts of one's situation and
prospects.
Questionable psychotherapy techniques continue to flourish even
though they rely almost solely on the same promotional techniques used
to sell worthless patent medicines.
233
A recent newspaper headline reported "Girl Dies After 'Therapy':
231. E.g., ROBYN M. DAWES, HOUSE OF CARDS: PSYCHOLOGY AND PSYCHOTHERAPY
BUILT ON MYTH (1994); MARGARET A. HAGEN, PH.D., WHORES OF THE COURT (1997);
DINEEN, supra note 97; E. FULLER TORREY, M.D., FREUDIAN FRAUD (1992).
232. See e.g., Daubert v. Merrell Dow Pharmaceuticals, Inc. 509 U.S. 579 (1993);
General Elec. Co. v. Joiner, 522 U.S. 136 (1997); Kumho Tire Co, Ltd v. Carmichael, 526
U.S. 137 (1999).
233. YOUNG, TOADSTOOL MILLIONAIRES, supra note 159; YOUNG, PURE FOOD, supra note
159.
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Five Charged with Abuse. ' 234 The article detailed the story of the death
of a ten year old girl at the hands of therapists practicing a form of
therapy known as rebirthing. The lead paragraph capsulizes this
tragedy.
"Wrapped in a flannel blanket meant to represent the womb, 10 year
old Candace Newmaker cried again and again that she couldn't breathe
as therapists pushed against her with pillows, urging her to fight her way
out and become 'reborn' ."..235
When the therapists finally unwrapped her she was not breathing and
lying in her own vomit.2 36 She died of asphyxiation a day later.237
Rebirthing is a technique that was started in the early 1970s. It has
been on the fringe of mainstream psychology ever since. Its originator,
Leonard Or, developed his theories while spending time in his hot tub
having revelations. He began to suspend his friends in the hot tub with
snorkels and nose plugs. Many of them reported they began to get in
touch with some of their own destructive behavior patterns. Some
reported "they experienced their own birth during the process. '238
A review of the history of rebirthing reveals its pattern similarity with
other questionable psychotherapy practices. Today, there are numerous
people, including Orr and others who actively promote and teach this
technique. Now called the Association of Rebirth International, they
give weekend training sessions to teach participants the rebirthing
experience as well as sessions to certify trainers in this technique. They
have lists of "certified" trainers throughout the United States.
One of the very powerful tools used by today's purveyors of the
unproved is the Internet. Indeed, the Internet is simultaneously the best
and the worst source of reliable information about medical or
psychological techniques or treatments. Any search engine will lead
234. Girl Dies After "Therapy" Five Charged with Abuse, SAN DIEGO UNION TRIB., July
9, 2000, at Al1.
235. Id.
236. Id.
237. Id.
238. SINGER & LALICH, supra note 5, at 42-43. Singer and Lalich describe rebirthing as
follows:
[D]amage is done to the breathing mechanism at birth because the child is
cut off from its supply of oxygen through the premature cutting of the
umbilical cord. This initial panic ("breathe or die") remains in the person's
subconscious as a nameless fear. The goal of the rebirthing process is to get
the person to release this long-held tension and learn to take advantage of the
fully functioning breathing mechanism. Once accomplished, the person can
lead a full, happy breathy life.
you to numerous websites that have very professional sounding titles
and credentials and memberships. What today's websites represent is a
repackaging of the same basic techniques used to promote and sell the
quack patent medicines of the nineteenth and early twentieth century.
Filled with powerfully personal testimonials and anecdotal evidence,
they very skillfully promote their nostrums as a powerfully effective
agent for change. 239
Thought Field Therapy ("TFT") is another newly emerging and
classically unproved psychotherapy technique. 240 One of the products of
the managed care revolution is the pressure on practitioners to produce
results in shorter time frames. 24 1 One of the cost-cutting measures was
to limit the number of visits to a psychotherapist that would be
reimbursed or covered by insurance. 242  In the wake of this pressure
came an emphasis on brief and short-term therapies. 243  Rather than
having unlimited time and funding to plumb the depths of every client's
past, the focus turned to dealing solely with a patient's presenting
problem. 244  One of these short-term therapy approaches was crisis
intervention. 245  "Crisis intervention involves having brief but intense
contact with victims of crisis or trauma for the purpose of calming them,
reducing risk, and returning them to their pre-crisis level of
functioning." 246
TFT is described as a "power" therapy due "to their claimed
remarkable facility in resolving severe or persistent emotional disorders
239. ld at 45. Singer and Lalich continue:
An additional factor that tends to make a risky situation worse is that
some forms of therapy-which initially might gain support as "a
breakthrough," "creative," or "innovative"-are not inspected critically by the
professional community. Instead, theses therapies are allowed to harm a
number of patients until the courts are asked to evaluate the conduct of the
therapists, the rationality of the therapy, and the extent of the damage done.
Sometimes public inspection or legal redress never occurs, and the therapies
continue to be promoted for decades ... with the on-going potential for
outlandish or disastrous consequences.
Id.
240. ROGER J. CALLAHAN, PH.D., THE FIVE MINUTE PHOBIA CURE: DR. CALLAHAN'S
TREATMENT FOR FEARS, PHOBIAS, AND SELF-SABOTAGE (1985).
241. Id.
242. Id.
243. Id.
244. Id.
245. Id.
246. David X. Swenson, Thought Field Therapy: Still Searching for the Quick Fix, 7
SKEPTIc 60 (1999).
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and trauma. ' 247 TFT uses sequences of finger tapping on acupressure
points, and combinations of sensory activities such as repeating
statements, counting, rolling the eyes, or humming a tune, while
thinking of the distressing situation. 248  The promoters of TFT make
extraordinary claims of healing of many physical and psychological
conditions. 249
TFT was invented by a psychologist, Roger Callahan.25 0  He
accidentally discovered it while treating a patient named Mary who had
a severe fear of water.25' Inspired by an acupuncture class he was taking
at the time, he instructed Mary to firmly tap under her eye with her
fingers, which lead to a miraculous and immediate resolution of her
phobia. 2  From this he developed a comprehensive set of techniques
and theories. 253 TFT is based on the idea that:
... invisible energy fields called "thought fields" exist
within the body. Environmental traumas and inherited
predispositions are theorized to cause blockages, or what
Callahan terms "perturbations" in the flow of energy in
these thought fields. Callahan theorizes that the
commonly observed neurochemical, behavioral, and
cognitive indicators of disorders such as depression are
the result of these perturbations. In other words, the root
cause of all psychological problems are blockages in
energy fields. 254
Not surprisingly, TFT is marketed primarily through the Internet. It
has numerous websites and markets a variety of courses for both
patients and therapists. 255
247. Id. at 61.
248. Id.
249. Id Swenson notes:
Thought Field Therapy claims to heal the following disorders: trauma(effects of rape, abuse, crime, war), phobias, anxiety, addictions, grief,
physical pain, panic, obsessive-compulsive disorders, eating disorders,
depression, chronic anger, guilt, self sabotage, food addictions, rejection,
sexual problems, fibromyalgia, migraine headaches, and love pain. There is
even a suggestion that it might cure cancer.
Id. (citations omitted).
250. Brandon A. Gaudiano & James D. Herbert, Can We Really Tap Our ProblemsAway? A Critical Analysis of Thought Field Therapy, SKEPTICAL INQUIRER 29,30 (2000).
251. Id.
252. Id.
253. Id.
254. Id. (citations omitted).
255. Id. at 30-3 1. The authors stated:
To attract potential therapists to take TIT courses and to persuade
Like rebirthing, facilitated communications, and other faddish
psychotherapy techniques, TFT is fueled by uncritical acceptance and
entrepreneurial zeal. 256
XIII. INFORMED CONSENT AND ACCOUNTABILITY
A fully implemented doctrine of informed consent stands ready to
operate internally within the mental health profession as a self
regulatory stimulus to more enlightened practice. Informed consent has
profound implications for the improved practice of mental health care.
A profession that actually practices informed consent is a profession that
is accountable. This is so because, at its core, informed consent requires
a practitioner to have an adequate knowledge base about his or her own
profession. To give informed consent, one must know the risks and
benefits of mental health interventions as well as know the risks and
benefits of not engaging in therapy.
The mental health professions have resisted informed consent for one
central reason. It would limit and restrict a large amount of
psychotherapy practice. Practitioners would be required to explicitly
state facts demonstrating their own lack of knowledge and the lack of
sound evidence to support what they are proposing. Informed consent is
so problematic for the mental health profession because
psychotherapists don't know what to inform their patients. It is a
profession ill informed about its own intellectual and scientific
background and very self-conscious about it.257
Informed consent threatens their self-view and the exalted status they
prospective clients to pay for this therapeutic approach, amazing claims are
presented on several TFV -related Web sites. For example, Callahan's
primary Web site claims that TFT allows individuals "to eliminate most
negative emotions within minutes." Callahan asserts that TFT's effectiveness
increases with higher levels of training. For example, another Web site
publicizes that therapists can achieve an 80 precedent effectiveness rate
learning to use specific algorithms, a 90-95 percent effectiveness rate from
using "Causal Diagnostic" techniques, and an over 97 percent effectiveness
rate suing a technique mysteriously termed "Voice Technology." Yet
another web site, this one based in the United Kingdom, states that TFV is the
only psychotherapy that can "genuinely claim to offer a cure.
Id.
256. Id. at 31. "Despite these miraculous assertions, no controlled studies have been
published in peer-reviewed scientific journals to provide evidence for TFT's claims.
Instead, testimonials and uncontrolled case studies are offered to support these astonishing
declarations of success." Id. (citations omitted).
257. See Stephen E. Hjelt, Professional Psychology: A View from the Bench, 26 REG.
REP. 8, (2000).
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have come to occupy. For many mental health practitioners, it is an
unwelcome reminder of their own lack of knowledge.
For a profession that relies on human memory for its basic currency,
the mental health profession has demonstrated a profound lack of
understanding of the basic science of memory. In the wake of what has
been described as an epidemic of recovered memories of childhood
sexual abuse, Michael Yapko, a respected authority on suggestibility,
memory and the clinical use of hypnosis, in the early 1990s gathered
data from therapists throughout the United States concerning their ideas
and practices regarding the roles of suggestion and memory in therapy.
He was most interested in determining whether therapists were thinking
critically and in an informed manner about these subjects.258
Yapko devised two questionnaires. The first, called a Memory
Attitude Questionnaire ("MAQ") was designed to assess the range and
depth of therapists' understanding of the workings of human memory,
particularly in relation to clinical issues and treatment. The second,
called the Hypnosis Attitude Questionnaire ("HAQ") was created to
assess how therapists view hypnosis as a method of retrieving memories
and the role of suggestibility in the therapy process.
The responses were so disturbing because they revealed widespread
ignorance of basis foundational facts. Unfortunately, the consuming
public is not aware of this. 259
258. MICHAEL YAPKO, SUGGESTIONS OF ABUSE 20-21 (Simon & Schuster 1994).
Yapko's blunt conclusion was:
I was dismayed, to say the least, by what I found. It is not an
exaggeration to say that many therapists appear to practice their profession
on the basis of sheer myth .. .The survey data I have gathered make it
abundantly clear that too many therapists treat their clients on the basis of
personal beliefs and philosophy, rather than according to an objective
consideration of the facts. Too many therapists seem ignorant about the
suggestibility inherent in the therapy process, and ignorant about the
workings of human memory, even though memory is central to the enterprise
of identifying and treating survivors.
Id.
259. Id. at 43. Yapko continued:
The general public seems to believe that mental health professionals serve
their clients on the basis of objective diagnosis and well-established, reliable
methods of treatment. Unfortunately, this is not the case. Psychotherapy
involves a unique blend of art and science, but it is mostly art. Consequently,
skill levels vary quite dramatically, as do perspectives about treatment.
During the time I have beeh in practice, I have seen many diagnostic and
treatment fads come and go. At any given time, there is an "in" diagnosis
and a "revolutionary new approach" to therapy, which are often greeted
enthusiastically by the profession but with little of the objectivity necessary
to evaluate accuracy and effectiveness.
One of the specific areas of focus of the MAQ was therapist attitudes
regarding memory, specifically its degree of accuracy and reliability.260
One of the specific areas assessed by the HAQ dealt with the relative
value of hypnosis as a therapeutic tool and its utility as a tool of memory
enhancement. Yapko, a leading authority on hypnosis, was very pleased
that an overwhelming majority (ninety-seven percent) viewed hypnosis
in a very positive light. He was not as impressed by other findings.26'
Much of what HAQ respondents believed about hypnosis were
myths. 262
In summarizing the findings regarding therapist attitudes toward
hypnosis, Yapko found the overall response pattern indicative of grave
cause for concern. 263
Informed consent in medicine and the mental health context has been
called many things: myth, charade, fairytale or fiction. While its uneasy
existence is occasionally observed in the delivery of medical care, its
Id.
260. Id. at 51-52. Yapko further stated:
About one in ten therapists surveyed believed that "memory is not
significantly influenced by suggestion," in direct contradiction to one of the
most basic and well-known facts about memory. The statement "One's level
of certainty about a memory is strongly positively correlated with that
memory's accuracy" was designed to get at beliefs about the relationship
between feeling right and being right. Feeling certain you are correct has
nomore to do with actually being right ... than shouting louder in an
argument does, but nearly one in four respondents believed that feeling
certain about a memory means the memory is more likely to be correct. And
41 percent believed that ".. .early memories, even from the first year of life,
are accurately stored and retrievable".
Id.
261. Id. at 54. "Nearly half the respondents (47 percent) agreed with the statement
'Therapists can have greater faith in details of a traumatic event when obtained hypnotically
than otherwise.' Attributing greater accuracy to a memory recovered hypnotically is a
distortion of fact with potentially hazardous consequences for the client." Id.
262. Id. at 58-59. Yapko noted that "[a] commonly held misconception is that 'people
cannot lie when in hypnosis."' Id. Nothing could be further from the truth. Hypnosis is not
a lie detector, nor does it prevent either intentional or unintentional deception on the part of
the hypnotized person. Id. Yet, nearly one in five respondents (18 percent) actually
believed this myth. Id. Even if they do not conduct the hypnosis sessions themselves, they
will likely believe those clients who tell them, "during a hypnosis session, I discovered I was
sexually abused." A similar percentage (19 percent) subscribed to the myth that "someone
could be hypnotically age regressed and get 'stuck' at a prior age." Id. "It is a virtual
impossibility to get 'stuck' in age regression in particular, or in any hypnotic experience in
general." Id.
263. Id. at 60 ("While the great majority of therapists are well intentioned people who
genuinely want to help their clients, the survey data make it abundantly clear that too many
therapists hold beliefs that are sometimes arbitrary, sometimes sheer myth, and sometimes
outright dangerous to their clients' well-being.").
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presence in the mental health context is fleeting at best. There is a
tremendous irony in this. Psychotherapy is the perfect setting for the
implementation of an effective informed consent. By its very nature, it
supplies fertile soil for planting the seeds of informed consent. It is far
more congenial for this purpose than contemporary medicine.
Psychotherapy is a uniquely intimate enterprise where faqade and
pretense are discouraged and a trusting relationship built on disclosure
and safety is promoted. Psychotherapy is an intense type of relationship
where the treatment is, in essence, a dialogue that extends over weeks,
months, and sometimes years.
Modern medicine is increasingly anonymous and impersonal, and is
not fertile ground for the discussions and decisions facilitated by trust.264
In the era of managed care and corporate medicine, the idealized close
and trusting relationship between patient and physician has all but
disappeared. Often patients do not even know the physician who treats
them. The image of the "family physician," of Marcus Welby, M.D., is
obsolete.
The vast divide separating doctors and patients is not solely a
function of differing values and beliefs or the impersonality of modern
medicine. It reflects a suspicion on the part of patients of the motives of
the medical profession. 265 This pervasive distrust is coupled with the
first hand experience, for most consumers of medical care, of "the
assembly line character of modern medicine". 266
264. WEAR, supra note 3, at 36-37. Wear describes this as "Patients and Physicians as
Moral Strangers":
In the past, the predominant image was of the wise and beneficent
physician, trusted and at times adored by his patients. The new ethos,
however, offers us a quite different and rather jaundiced vision. In a nutshell,
this view runs as follows. Medicine is an enterprise pursued within a secular,
pluralistic society in which physicians and patients meet as moral strangers
in various senses.
Id.
265. Id. at 35-36. Wear continued:
Somehow or other, a deep core of distrust has developed regarding the
intentions and capabilities of the medical profession.
.. this vision dovetails well with widespread postwar distrust of societal
institutions and expertise. Allied to such distrust is the perception that the
sciences, biological and otherwise, have been unable to generate sufficient
moral sensitivity and insight to match their rapidly expanding knowledge and
technical capacity, and that the interests and freedom of the citizenry have
been placed in jeopardy as a result.
Id. at 36.
266. Id. at 37. Wear further stated:
Care and treatment in hospitals are fragmented across loosely coordinated
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It is very difficult to dispute this view of modern medicine. It is an
enterprise conducted mainly by strangers who don't know each other
and don't share the same values and beliefs. It is hard to think of soil
more hostile and inhospitable to the growth and nurturance of informed
consent. Why not consider psychotherapy, the erstwhile estranged
distant relation to informed consent.
XIV. HUMAN MISERY
Even if fully operational, no amount of informed consent will, on its
own, protect consumers from exposure to harmful therapy techniques.
Human distress and lack of expertise are a potent combination that will
always place a mental health professional in a position to persuade the
unsuspecting and the needy of the benefits of an exciting and
"promising" new technique.
Psychotherapy is the paradigmatic psychic contract of adhesion.
267
For the vast majority of those who seek help through psychotherapy
there is no equal bargaining power. There is someone who is needy,
distressed, demoralized or discouraged who is turning to a specialist
because, most often, such person has been incapable of solving the
problem themselves. The psychotherapist-patient relationship creates a
synthetic form of intimacy through which a needy patient discloses all
her secrets, fears, fantasies, shame and failures.
Psychotherapy is truly an "invasive procedure. '268 It courses through
team members and shifts. Often there is either no one clear person directly in
charge of the individual patient's care, or even if there is, it is an overworked
resident rotating across services, or a tightly scheduled community physician
who stops by to check on his patient within a grueling daily marathon from
hospital to clinic to private office. Often, in fact, hospitalized patients are
essentially doctorless. They are picked up by residents who know nothing of
their background and have little or no connection with the patient's private
physician (if the patient has one, which he often does not). Further, such
residents tend to be quite hesitant even to initiate a personal relationship, or
investigate the patient's fears, needs, and desires, as they will probably not
have the opportunity to pursue such matters in more than a quite cursory
manner. So the personal interaction remains at best pro forma and minimal.
Id.
267. See Neal v. State Farm Ins. Co., 10 Cal. Rptr. 781, 784 (Cal. Dist. Ct. App. 1961).
Contracts of adhesion are agreements that are imposed and drafted by the party of superior
bargaining strength thus relegating to the subscribing party only the opportunity to adhere to
the contract or reject it. Id. "Such an agreement does not issue from that freedom in
bargaining and equality of bargaining which are the theoretical parents of the American law
of contracts." Id.
268. See POPE & VASQUEZ, supra note 199, at 37 ("Metaphorically, psychotherapy, like
surgery, is an 'invasive procedure', although in both cases the client or patient consents to
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one's blood and brain in the same way that an antibiotic or an
antidepressant does. Psychotherapy exposes the secrets of one's heart
and mind in the same way a CT scan or MRI exposes tissues, bones and
organs. When you couple the special expertise of the therapist, his
exalted social status, and the often mythic and magical views promoted
or held by many, you have a prescription for potential disaster.
All mental health disciplines have as part of the foundational body of
knowledge the notion of transference and counter-transference. These
notions trace their development to Sigmund Freud, who posited that a
patient would transfer onto the therapist feelings from authority figures
in early life and attempt to act out with the therapist the same role.269
Transference and counter-transference are, more than anything,
examples of the social influence process that is at the heart of
psychotherapy. A therapist and a patient influence each other by virtue
of their interactions in therapy, although the influence is certainly not
symmetrical. The social influence process of psychotherapy is
decidedly asymmetrical as a result of a transference. However, this has
nothing to do with psychodynamic conceptions of the term. Rather, it
concerns the transfer of power from the patient to the therapist by virtue
of the patient's neediness and demoralization, and the patient's
revelations of secrets, which create a profound moment of vulnerability
and exposure.
This transfer of power and subsequent vulnerability and exposure is
precisely why no amount of informed consent can fully protect those
who are desperate from taking a chance with someone offering hope of a
cure or relief from distress. This is why fake claims of cures for cancer
and AIDS continue to be promoted both here and abroad. Fortunately,
the FDA drug approval process makes it impossible for these nostrums
to be marketed by legitimate health care professionals. The process
provides substantial protection for the most vulnerable of us who might
be prepared to take a chance on a cure because alternative prospects are
so bleak.
In situations of vastly unequal bargaining power, informed consent is
easily ignored or manipulated. The psychotherapist patient relationship
is a psychic contract of adhesion from its inception. The typical
ingredients of patient neediness and distress, and the exalted special
the invasion.").
269. Jim Hagart & John Albutt, Freudian Psychology: The Basis of Psychotherapeutic
Interventions (Nov. 1, 2002), http://sss-student.tees.oc.uk/psychology/modules/year3/
abnormal/lec9.htm.
place accorded to the healer create, ab initio, a relationship where the
bargaining power is inherently uneven.
A new psychotherapy technique, is of course, never promoted as
experimental, untested, untried, potentially harmful or lacking proof that
it works as it is advertised. It is always referred to as new and exciting;
exciting because of the positive results seen by the therapist. When a
therapist has great success using a technique on patients with your
particular problem, or there are reports of success or promising results in
the professional literature, it is a potent form of persuasion. It is
unrealistic to expect a patient under these circumstances to ask whether
there is persuasive empirical research data to support the safety and
efficacy of the therapeutic intervention you are proposing.
XV. THE NEED FOR REGULATORY OVERSIGHT
What is necessary, in addition to informed consent, is an external
mechanism that is concerned with efficacy and safety. The principal
product of the mental health enterprise, psychotherapy, is a commodity
that has the essential hallmarks of a drug or medical device. There are
many different types. Considering the long history of exposure of a
vulnerable and unsuspecting public to the questionable and sometimes
harmful, psychotherapeutic interventions should not be allowed unless
proven safe and effective. The burden should be on the promoters of a
particular mode of therapy to demonstrate through well-designed
clinical studies that what is promoted works.
The history of exposure of the vulnerable and unsuspecting to the
questionable and the harmful is well-documented in medicine. Indeed,
FDA history is best described by two struggles; first, against the
nostrums and patent medicines of a more primitive era; and then, against
drugs such as thalidomide in the early 1960s, where the risks of harm
caused by the drug far outweighed then potential benefits. The FDA
represents an organized societal response to the grave risks threatening
public health from exposure to worthless and/or harmful medicines and
therapies. Because of the potential for grave harm, the FDA developed,
through Congressional action, a unique regulatory scheme that declares
protecting the public as its primary motivating strategy. This regulatory
scheme evolved over the last 100 years in a manner dictated more by
public health tragedies than anything else. As such, it has been a
creature of the political process, as consumers, their advocates and
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pharmaceutical companies have lobbied over the years. 270
A brief review of historical milestones is helpful in understanding the
regulatory scheme that exists today. In 1906, Congress passed the
Federal Food, Drug, and Cosmetic Act.271 The twenty years prior to the
passage of the act was the heyday of the patent medicine. 272
Although the 1906 Act was viewed as a watershed event, it only
required that drugs meet standards of strength and purity.2 73 The burden
of proof was on the FDA to show that a drug's labeling was false and
fraudulent before it could be taken off the market.274
By the early 1930s, the 1906 Act was essentially obsolete.275 A bill
was introduced in the United States Senate in 1933 to completely revise
the 1906 drug law.276  Drug companies resisted change and
Congressional action stalled until 1938, when 107 people died from a
poisonous ingredient in "Elixir Sulfanilamide."2 77  Congress passed a
compromise bill which, for the first time, required manufacturers to
prove the safety of a drug before marketing it.278
270. Elizabeth Rutherford, The FDA and "Privatization"--The Drug Approval Process,
50 FooD & DRUG L.J. 203, 215 (1995) ("The FDA's regulatory framework necessarily
reflects these political realities, because Congress created the regulatory scheme that was
primarily a result of public health tragedies. Congress has made the FDA a powerful
bureaucratic gatekeeper, by giving it absolute control over new drug approvals, as well as
post-market enforcement.").
271. Wallace F. Janssen, Outline of the History of U.S. Drug Regulation and Labeling,
36 FOOD DRUG COSM. L.J. 420, 421-422 (1981). Wallace F. Janssen, described the event in
these terms:
On June 30, 1906, President Theodore Roosevelt signed the original Pure
Food and Drugs Act ... [n]o single event has had greater significance in the
history of consumer protection laws or the industries they regulate. It
signaled the beginning of an era of progress in these areas which had no
precedent.
Id.
272. Id. at 422. Janssen further noted:
[Tihis was the heyday of "patent medicines" such as Kick-A-Poo Indian
Sagwa and Warner's Safe Cure for Diabetes. The existence of thousands of
these products reflected both the limited medical knowledge of the period
and public acceptance of the doctrine that buyers should look out for
themselves. Nostrums were so common that they were largely taken for
granted-a part of the normal American scene. Anyone, no matter how
ignorant or unqualified, could go into the drug manufacturing business.
Id.
273. Id. at 427-28.
274. Id.
275. Id
276. Id at 429.
277. Id.
278. Id.
In 1951, Congress passed the Durham-Humphrey Amendment, which
mandated the labeling of certain drugs for sale by prescription only.
279
Until the passage of this amendment, there was no requirement that any
drug be labeled for sale by prescription only.28° The amendment defined
prescription drugs as those unsafe for self-medication and those
appropriate for use only under a doctor's supervision.281
In 1962, Congress passed the Kefauver-Harris Drug Amendments.
282
As was typical with proposed legislation, there was strong opposition to
it.283 Thalidomide changed all that.284
The Drug Amendments of 1962 passed unanimously, containing a
number of new and powerful provisions:
285
1) Drug companies were required to register their
establishments with the FDA and to be inspected at least
every two years; 2) pertinent records were required to be
kept and made available for inspection; 3) reports of
adverse drug effects were required to be promptly
transmitted to the FDA; 4) regulation of advertising of
prescription drugs was transferred from the Federal Trade
Commission to the FDA and the copy required to include
full information on adverse effects and contraindications so
279. Id. at 434-35.
280. Id.
281. Id. at 435.
282. Id at 437.
283. Id
284. Id. Janssen reports on the enactment in these terms:
But in the early summer of 1962, complacency vanished abruptly as a
horrifying story unfolded of the narrow escape of American families from the
tragedy of grotesque deformities in babies caused in European countries by a
supposedly safe new sleeping pill. Thalidomide was not marketed
commercially in the United States because the new drug safety clearance
requirements of 1938 had been applied by an FDA medical officer, Dr.
Frances 0. Kelsey, who refused to release the drug on what she believed was
inadequate evidence ....
Thalidomide had been distributed to over 1,000 doctors in the U.S. as an
investigational drug. Seventeen cases of birth defects were connected to its
use, ten traced to purchase of the drug in other countries. As the extent of
this distribution was learned, it became apparent that a tightening of controls
over investigational drugs was also needed. Proposed new regulations were
issued; Congress quickened its pace on the pending drug legislation. As
statutory gaps in consumer protection came to be interpreted in terms of
deformed babies, public clamor arose for strengthening the law in every
respect to close those gaps.
Id.
285. Id. at 438.
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as to provide a balanced picture; 5) new investigational
drug provisions required informed patient consent before
trials on human subjects, and, 6) effectiveness as well as
safety of new drugs was required to be shown by
substantial evidence from controlled studies to obtain FDA
approval for marketing. 216
The last provision was a powerful new regulatory tool. Before
marketing a drug, a pharmaceutical company now had to prove not only
safety, but also effectiveness for the drug's intended use. 287
There have been further changes to the Federal Food, Drug, and
Cosmetic Act, particularly in the last ten years. The changes resulted
from intense pressure by the pharmaceutical industry and conservatives
in Congress to reduce what they claimed is the heavy handed and
onerous burdens imposed by a regulatory body that takes forever to
approve a new drug and unnecessarily cost the industry billions of
dollars in cost. They also complained that the Act ultimately denied the
public the benefit of new and promising medications. Accordingly,
there were strong pressures to privatize the regulation of drugs.
In 1992, Congress enacted the Prescription Drug User Fee Act,288
which required that manufacturers pay user fees for certain new drug
applications and supplements along with annual establishment fees and
annual product fees.28 9 In exchange, the FDA hired hundreds of new
staff to expedite the approval process. 290 Also in 1992, the FDA created
the Abbreviated New Drug Application ("ANDA").291 This created a
simplified submission process for products with the same or very closely
related active ingredients, dosage form, strength of administration, use
and labeling as a product that has already been shown to be safe and
effective.292 Also, the FDA implemented an accelerated approval
procedure. 293
286. Id
287. Id.
288. Prescription Drug User Fee Act of 1992, 21 U.S.C. §§ 301-379 (West 2000).
289. 21 U.S.C.A. § 379(h)(a)(1)(A) (West 2002) (amended 2002).
290. 21 U.S.C.A. § 379(f)-(h) (West 2002).
291. 21 U.S.C.A. § 3550) (West Supp. 1999).
292. Id.
293. CENTER FOR DRUG EVALUATION AND RESEARCH, U.S. FOOD AND DRUG
ADMINISTRATION, BENEFIT VS. RISK: How CDER APPROVES NEW DRUGS, available at
http://www.fda.gov/cder/about/whatwedo/testtube-5.pdf (Sept. 1999). "A highly specialized
mechanism intended to speed approval of drugs promising significant benefit over existing
therapy for serious or life-threatening illnesses." Id. at *6. It incorporates elements aimed at
making sure that rapid review and approval is balanced by safeguards to protect both the
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What the FDA does, in its regulatory role, is balance benefits and
risks. Due to various pressures, this role continues to change in
emphasis. Its regulatory role, however, remains firmly in place despite
efforts to gut its authority during the mid-90s. It sped up the review
process, and on balance, this is good for consumers and the industry it
regulates. However, the recent experience with the diabetes drug
Rezulin is a case study of how the risk-benefit analysis can be
improperly distorted by pressure from the self-interested parties the
FDA is supposed to regulate.
The FDA granted "fast track" approval to the drug Rezulin on
January 29, 1997.294 Even before the grant of the final application, the
manufacturer Warner-Lambert was heavily marketing the drug for
potential use in treating Type II, or adult onset, diabetes.
295
Warner-Lambert submitted its new drug application for Rezulin in
July 1996 and, for the first time in its history, the FDA granted a six
month fast-track review to a diabetes pill.296 The FDA assigned Dr.
John Gueriguian to determine the safety and efficacy of the drug.
297
public health and the integrity of the regulatory process. Id. at *6.
294. David Willman, Rezulin's Effect on Heart Was Also Seen as Concern, L.A. TIMES,
March 23, 2000 at Al.
295. David Willman, The Rise and Fall of the Killer Drug Rezulin, L.A. TIMES, June 4,
2000 at Al. Willman Reported:
By May 15, 1995 ... Warner-Lambert was moving to position Rezulin
for heavy sales. The company... launched a multi-tiered strategy for
transforming Rezulin into a "billion dollar blockbuster." Early slide-show
pitches were made to Wall Street analysts, emphasizing the market of
America's 15 million adult-onset diabetics and touting Rezulin's "new
mechanism of action."
Warner-Lambert and its affiliates paid speaking or other fees to more than
300 doctors, from endocrinologists to family practitioners. The company
flew diabetes specialists to the 1996 Olympic Games in Atlanta and provided
accommodations at the Chateau Elan Winery and Resort.
Warner-Lambert also put on its payroll the government's top diabetes
researcher, Dr. Richard C. Eastman, who at the same time oversaw the
selection of Rezulin for use in a National Institutes of Health clinical trial.
Id.
296. Id.
297. Willman, supra note 294. Willman reports:
By the fall of 1996, Gueriguian concluded that Rezulin was unfit for
approval and warned of its potential to harm both the liver and the heart. But
Gueriguian came under fire from Warner-Lambert executives, who contacted
the FDA's Lumpkin to complain about Gueriguian's use of intemperate
language.
Effective November 4, 1996, Lumpkin ordered Gueriguian removed from
the evaluation of Rezulin and any further dealings with Warner-Lambert,
according to physicians familiar with the matter. Gueriguian's medical
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From the time of approval, evidence began to surface that suggested
that there may be serious health problems associated with Rezulin.298
Despite mounting evidence of serious, often fatal, consequences linked
to Rezulin, the FDA refused to remove the drug from the market.299
Only after investigative reporting by the Los Angeles Times and the
courageous actions of a few health officers within the FDA did the
agency finally conclude on March 21, 2000 to withdraw Rezulin from
the U.S. market.300
What is frightening about the Rezulin incident is the amount of access
and power that the FDA ceded to the manufacturer it was supposed to
regulate. Senior officers in the agency repeatedly ignored the advice of
those in the agency best positioned to speak intelligently about the
obvious health risks that had been uncovered. 30 1
The experience with Rezulin highlights, in clear relief, the necessity
for regulation and the need for insulation from the lobbying power of
those being regulated. The one tragic difference with Rezulin,
compared with the patent medicines of the past, is that Warner-Lambert
knew of the deaths from liver failure clearly associated with its drug,
and yet continued to actively lobby the FDA with carrot and stick to
keep the drug marketed.30 2 No clearer example for the need for
vigilance in regulation can be offered.
The history of the mental health profession in the last 100 years
reveals its own set of skeletons. The harm from questionable and
unproved techniques is substantial and continuing. There is no good
reason to allow this to continue. The exposure of the unsuspecting
public to ineffective or harmful psychotherapeutic techniques creates a
clear and present danger to the health and safety of millions of people.
Allowing the mental health profession to operate as it does now cannot
be justified on any sound public policy basis.
Although FDA-type regulatory oversight has never existed for
psychotherapy, there is a glaring need. More importantly, there are
regulatory and quasi-regulatory structures already in place that could
review also was purged from agency files. These actions sent an early and
enduring message within the FDA: [c]hallenging [r]ezulin was not without
risk to one's career.
Id.
298. Id.
299. Id.
300. Id
301. Id.
302. Id
perform this function.
XVI. TWO REGULATORY MODELS
There are two models of regulatory oversight that should be
considered: 1) the model of the Food and Drug Administration (FDA);
and 2) the model of the National Institute of Mental Health (NIMH).
Both have strengths and weaknesses that must be assessed. However,
both can provide an external review that can insure efficacy and safety.
The FDA has been, to some, the poster child for a bloated and non-
responsive bureaucracy. The pharmaceutical industry has often
complained about the immense expense and the lengthy approval
process. 303
However, the last decade has seen improvements in the speed and
efficiency with which the FDA acts. It has also seen, with Rezulin, what
happens when the primary goal of public protection is diluted by
industry meddling.
The FDA performs many functions, but its main function is to see
that drugs marketed to consumers are safe and effective. 31 It has three
basic roles: first, it acts as a regulator in promulgating rules and carrying
out its legislative mandate; 30 5 second, it acts as a scientist, analyzing the
scientific data and doing research into the risks and benefits of these
products; 30 6 and third, it acts as an educator, by instructing consumers
and the regulated industry about matters of public health.30 7
The Food, Drug & Cosmetic Act defines "drug" and "new drug," thus
identifying the products which are subject to the drug approval process.
308 The Act also identifies the criteria by which all new drugs are to be
evaluated in order to gain marketing approval. 3 9  The Act gives the
303. See Rutherford, supra note 270, at 214. Rutherford writes:
It takes pharmaceutical companies approximately twelve years and an
average of $359,000,000 to discover and develop a new medicine.
Approximately two years of this development time is devoted to FDA review
of the firm's new drug application (NDA). For all this time and effort and
expense, the FDA only approved twenty two new drugs in 1994.
Id.
304. AN FDA OVERVIEW: PROTECTING CONSUMERS, PROTECTING PUBLIC HEALTH, U.S.
FOOD & DRUG ADMINISTRATION OFFICE OF PUBLIC AFFAIRS 1 (April 2000), available at
http://www.fda.gov/oc/opacom/fda 101/text. html.
305. Id.
306. Id.
307. Id
308. 21 U.S.C. § 321 (g), (p) (West Supp. 1999).
309. 21 U.S.C. §§ 351-360 (West Supp. 1999).
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FDA the broad power to interpret, implement and enforce the statute.310
The statute provides that the manufacturer must supply "substantial
evidence" of effectiveness prior to a drug's approval, but it is the FDA
in its interpretive role, that decides what constitutes substantial
evidence. 311 In accomplishing this, it also determines what quality of
scientific testing and data accumulations are satisfactory to obtain
market approval.312
The FDA, as interpreter of the Act, must communicate its policies
and standards to the industry. It does so by developing and publishing
regulations in the United States Code of Federal Regulations (CFR).
The FDA also supplements the CFRs by publishing agency guidelines
which are meant to give drug sponsors more detailed guidance on
specific methods that would satisfy regulatory requirements.
There are three core activities in the development and approval
process for a new drug: 1) scientific testing designed to provide data on
a product's safety or effectiveness; 2) the preparation and submission of
these data and other information in regulatory applications; and 3)
review of regulatory submissions. 313
The ultimate pre-marketing proving ground for a new drug is the
clinical trial.314 However, even before clinical trials are begun, a
sponsor will seek some evidence that a compound is biologically active
and develop some preliminary data showing that the drug is reasonably
safe for use on humans. 315  In this pre-clinical stage, the FDA will
generally ask the sponsor to evaluate the drug's toxic and pharmacologic
effects through animal testing.316 This pre-clinical drug development
does not involve human exposure. 317
When a sponsor feels that it has adequate data to show that a new
drug is safe for initial small scale clinical studies, it collects the data and
submits an Investigational New Drug application (IND). 318  This
application permits beginning testing a drug on human subjects. 319 The
310. Id.
311. Id.
312. Id.
313.21 U.S.C. § 355 (West Supp. 1999).
314. Id.
315. Id.
316. Id.
317. Id.
318. See FDA INVESTIGATIONAL NEW DRUG (IND) APPLICATION PROCESS, available at
http://www.northwestern.edu/research/OPRS/irb/handbook/indl.doc (last visited Aug. 24,
2002).
319. Id.
IND review process determines whether enough information is
submitted to allow the clinical administration of the drug.320  This
review process involving chemistry and pharmacology ends with a
clinical review which evaluates the clinical protocols to insure that: 1)
the subjects will not be exposed to unreasonable and significant risks
during clinical trials; and 2) that Phase 2 and Phase 3 trials are adequate
in design to provide scientifically valid data.32' If a sponsor satisfies this
requirement, it is ready to conduct clinical trials; by far the most critical
stage in the drug approval process.322 The FDA has a very strict set of
requirements that must be adhered to in the conduct of the clinical
investigation.323 This is to protect the health of the human subjects and
to insure the integrity of the clinical data. Generally, clinical studies
begin and proceed cautiously. If the results are favorable, the
investigational drug is tested in progressively larger populations and in
some cases over longer periods and in higher doses.32 4
A typical clinical trial has the following structure:
1) Phase 1: Cautious use of a drug in a few patients or normal human
volunteers, to gain basic safety and pharmacology information (20-80
patients).325
2) Phase 2: Use of the drug in a small number of patients who suffer
from the condition that the drug is intended to treat or diagnose (100-
200 patients).326 This provides additional safety data and provides the
first indication of a drug's clinical effectiveness in its proposed use.
3) Phase 3: Use of the drug in a significantly larger group of subjects
who suffer from the target condition.327 Phase 3 trials are designed to
assess a drug's safety and effectiveness and to help determine the best
dosage in a larger and more varied population (several hundred-several
thousand patients).328
The NDA, or New Drug Application, is the vehicle through which
drug sponsors obtain FDA approval to market a new drug
320. Id.
321. Id
322. CLINICAL TRIALS, available at http://health.yahoo.com/health/clinical-trials/ilntro/
p04.html (last visited Aug. 24, 2002).
323. Id.
324. Id.
325. Id.
326. Id.
327. Id.
328. Id.
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commercially.329 In the application, the sponsor proposes that the drug
be approved and uses all the data collected to show that the drug is safe
and effective for its proposed indication.330 Multiple reviewers within
the FDA including a clinical reviewer, pharmacology/toxicology
reviewer, chemistry reviewer, statistical reviewer and biopharmaceutical
reviewer, process the application.331 During this review process, the
FDA may seek advice from one of its in-house advisory committees.33 2
If these strict criteria are met, a decision is made about approval.333
The National Institute of Mental Health (NIMH) is a very different
governmental agency than the FDA. The FDA is not a research
organization, although it is composed of countless research oriented
scientists. Instead, the FDA reviews the research of others and evaluates
the quality of that research as part of its overall regulatory oversight
duties. Created in 1946, the NIMH is a part of the federal National
Institutes of Health, which is the principal biomedical and behavioral
research agency of the United States Government and part of the U.S.
Department of Health and Human Services. 334
The NIMH is certainly not immune to politics, but it is at heart a
research institution devoted to the betterment of public health. 335
329. NEW DRUG APPLICATION (NDA) PROCESS (March 8, 2001), available at
http://www.fda.gov/cder/regulatory/applications/NDA.htm.
330. Id
331. Id
332. Id.
333. CENTER FOR DRUG EVALUATION AND RESEARCH, supra note 293. The CDER states:
In the final analysis, CDER's decision whether to approve a new drug for
marketing boils down to two questions: Do the results of well-controlled
studies provide substantial evidence of effectiveness. Do the results show the
product is safe under the conditions of use in the proposed labeling? Safe, in
this context, means that the benefits of the drug appear to outweigh its risks.
When the review is complete, CDER writes to the applicant to say the drug is
either approved for marketing, is approvable, provided minor changes are
made; or is not approvable because of major problems. Once CDER
approves the NDA, a drug is on the market as soon as the firm gets its
production and distribution systems going.
Id.
334. OFFICE OF COMMUNICATIONS AND PUBLIC LIAISON, NATIONAL INSTITUTE OF MENTAL
HEALTH, FACTS ABOUT NIMH (April 2000) at * 1, available at http://www.nimh.nih.gov/
about/factsabout.cfm.
335. Id. This publication describes its mission:
The mission of the National Institute of Mental Health (NIMH) is to
reduce the burden of mental illness through research on mind, brain, and
behavior. This public health mandate demands that NIMH harness powerful
scientific tools to achieve better understanding, treatment, and eventually
prevention and cure of mental illness.
Through research, NIMH and the scientists it supports seek to gain an
The total budget for NIMH for fiscal year 1999 was $859 million.336
Of this, 13 percent was spent on intramural research (on site at NIMH),
83 percent on extramural research at facilities across the country, and 4
percent was spent on research management support. 337
NIMH is involved in five separate activities in carrying out its
mission: 1) supporting research on mental disorders and the underlying
basic science of brain and behavior; 2) supporting research on these
topics at universities and hospitals around the U.S.; 3) collecting,
analyzing, and disseminating information on the causes, occurrence, and
treatment of mental disorders; 4) supporting the training of more than
1,000 scientists to carry out basic and clinical research; and 5)
communicating information to scientists, the public, the news media,
and primary care and mental health professionals about mental illness,
the brain, mental health, and research in these areas. 338
NIMH sponsors and conducts research in many important research
areas. One of the major research areas is Basic Behavioral and
Neuroscience Research which seeks:
to learn how such basic processes as cognition
(perception, attention, thought, memory, and learning)
emotion, and interpersonal interactions occur and play a role
in mental disorders. Research includes studies of:
-Interaction of genes and the environment in shaping the
brain
-Molecular and cellular level events involved in brain
function
-Brain circuits and their function
-Advanced technologies such as brain imaging, molecular
genetics, and computer modeling
-Basic cognitive processes such as conditioning
-Mechanisms underlying emotion
-Role of emotion in cognition
understanding of the fundamental mechanisms underlying thought, emotion,
and behavior-and an understanding of what goes wrong in the brain in mental
illness. The Institute strives, at the same time, to hasten the translation of this
basic knowledge into clinical research that will lead to better treatments and
ultimately be effective in our complex world with its diverse populations and
evolving health care systems.
Id. at *1.
336. Id.
337. Id.
338. Id.
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-Complex social processes 339
Other major research areas are depression, schizophrenia, anxiety
disorders, Attention Deficit Hyperactivity Disorder (ADHD), autism,
AIDS research, rural mental health, child and adolescent violence. 340 In
addition, NIMH funds studies in the areas of eating disorders, conducts
disorder, learning disorders, personality disorders, Alzheimer's disease
and related dementias, sleep disorders, and the prevalence of and risk
factors for mental disorders and mental health problems of special
populations, including racial and ethnic minorities and women. 341
NIMH also funds research studies at various universities and
hospitals through the awarding of grant funding.342 It also conducts
clinical trials.343
The clinical trials test methods for the diagnosis, treatment, risk
assessment or prediction and prevention of mental disorders. 344 NIMH
is currently conducting extramural clinical trials in the following areas:
-Systematic treatment enhancement program for Bipolar disorder
-Treatment of adolescent depression study
-Sequenced treatment alternatives to relieve depression
-Clinical antipsychotic trials of intervention effectiveness
-Hypericum clinical trials
-Is panic disorder inherited?345
NIMH research is not limited to studies of medications for serious
psychiatric conditions such as schizophrenia. 346 In fact, the NIMH has
conducted or sponsored rigorous clinical research studies on
psychosocial interventions such as psychotherapy. 347
XVII. CONCLUSION AND RECOMMENDATIONS
The suggestion that the delivery of psychotherapy services be
regulated in the same fashion as drugs or medical devices will no doubt
be met with rage and disdain within some segments of the mental health
profession. There is no question that governmental regulation comes
339. Id. at *2.
340. Id. at *24.
341. Id. at *4-5.
342. Id. at *5.
343. Id.
344. Id.
345. Id.
346. Id.
347. See MILLER & MAGRUDER, supra note 6.
with its own baggage of bureaucracy and inefficiency. The assault on
the FDA in the last fifteen years, however, has not resulted in the
dismantling of the agency and the privatization of public protection.
However, it has resulted in greater flexibility and efficiency in the drug
approval process.
Despite the acknowledged costs associated with a regulatory
bureaucracy, there will be, without question, many advantages. One of
them will be increased credibility for the mental health profession. At a
time when the profession is the subject of intense criticism both from
within and without, well-earned credibility as a science devoted to
treating emotional ills with empirically validated treatments carries with
it inestimable value.
The choice of the regulatory model (FDA or NIMH) is certainly not
without consequence. The models are quite different in how they
conduct business. Neither could perform this function of regulating
psychotherapy without new legislation and a broadening of their current
scope of operation. The FDA operates strictly as a regulatory agency,
whereas the NIMH is a research and funding agency.
The FDA certainly could regulate psychotherapy as it does drugs or
medical devices, but the FDA draws its statutory authority from its
power to regulate drugs and devices sold in interstate commerce.
Psychotherapy is not a commodity sold in interstate commerce.
The NIMH would need to have additional and very specific
regulatory powers granted to it by Congress. Empowering the NIMH,
as part of a new regulatory scheme, to determine what is required by
way of research to satisfy a "substantial evidence" of efficacy standard,
would be required. Alternatively, the NIMH could fund additional
studies to evaluate specific psychotherapies, and if proven to be
ineffective, common law negligence could be utilized to restrict such
practices, since they would no longer meet the standard of care. Such an
approach would rely on the content of the standard of care as it relates to
the mental health profession. In the past, there has been great ambiguity
as to what such a standard of care requires.
The NIMH has certain qualities that make it a more advantageous
choice. The paramount one is that it is already heavily involved in
supporting, conducting and evaluating rigorous empirically based
research on both psychopharmaceutical and psychotherapeutic
interventions. It has a track record of evaluating good science. It has
been evaluating the types of interventions that are the subject of this
article. It knows what to look for; it knows the questions to ask. It
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already has a large base of institutional knowledge on safety and
efficacy of some currently used psychotherapy techniques.
Additionally, it has sound, empirically supported research showing that
some psychotherapy interventions are safe and effective. 348 This is
crucial. By requiring proof of safety and efficacy before using a
psychotherapy technique, patients needing mental health services will
not, all of a sudden, be unable to engage in psychotherapy. They will,
however, be protected from exposure to bogus and harmful treatment.
The issue at its most basic level is quality control in health care.
Governmental control, through administrative regulation, is only one
source of this. The tort system and the market are others. In addition,
there are professional ethics and licensure. All of these potentially play
a role in the assurance of quality control in health care. However, it is
one of the central arguments of this article that the tort system (and the
doctrine of informed consent in particular), the market and professional
ethics and licensure have failed to prevent exposure of the needy and the
vulnerable to ineffective and potentially harmful psychotherapy
techniques.
The suggestion that psychotherapy should be regulated is not a casual
one and is not made without awareness of the challenges to the creation
of an effective regulatory body. The proliferation of unproved and
potentially harmful psychotherapy techniques is a public health issue so
important that it should not be left to the vagaries of the market. The
harm done by bogus psychotherapy is no different in its public
consequences than that caused by phony cancer or AIDS cures. They
each pose an imminent risk of harm to the needy and vulnerable.
The regulation of psychotherapy, as this article proposes, is justified
on the basis of the public health consequences of untreated and
improperly treated mental health conditions. Most health care matters
are not viewed as concerns of the federal government. These fall within
the exercise of the police power which is generally reserved to the
states. For example, health care matters regarding the standard of
practice and licensure are left to the states. However, there are some
matters deemed so important to public health and so national in
character that they demand federal attention. The Clean Air Act 349 that
created the Environmental Protection Agency ("EPA") is one such
example. Under the Clean Air Act, the EPA is charged with setting
national standards for certain air pollutants to protect both public health
348. Id.
349. The Clean Air Act Amendments of 1990, 42 U.S.C. § 7408 (1994).
and the environment.
The provision of long-term care in nursing homes is another example
of federal regulation in what historically was a state regulated exercise
of the police power. Long-term care is a very important and growing
portion of the nation's health care sector. As a result of competitive
market pressures, the distinction between nursing homes and hospitals
and the services they provide is blurring. In addition to their traditional
custodial or supportive role, nursing homes are treating increasingly
sicker patients with increasing medical needs. The federal government
largely deferred quality control regulation of nursing homes to the state
licensure systems until the late 1980s. However, in 1987, the federal
government undertook a very significant new role in the enforcement of
quality of care standards in the nursing home industry. 350
The NIi4H is the preferred choice for another reason specifically
addressing another difference between psychotherapy research and
pharmaceutical research. As previously noted, the FDA is structured
around a model in which the agency primarily reviews the research
work of others. This works well when the marketplace provides the
necessary incentives for pharmaceutical companies to spend the large
amount of money needed to research and test a new drug. In the case of
the pharmaceutical industry, the economic incentive is very basic. The
industry cannot sell a new drug in interstate commerce without prior
approval of the FDA.
Psychotherapy research does not enjoy the same place in terms of
market incentives. Historically, funding for psychotherapy research has
been almost entirely government supported, almost exclusively within
the NIMH. The mental health field itself has been very deficient in
supplying funds to support research, due in large part to its roots as a
"cottage industry." Furthermore, professional societies such as the
American Psychiatric Association and the American Psychological
Association have failed to take an active role in developing independent
funding sources for such a central activity of their professions. In
addition, there has not been an industrial base in psychotherapy to
support research and development like there is in the pharmaceutical
industry.351
Government support of psychotherapy research is not adequate to
fully fund all the research necessary to determine safety and efficacy of
350. FuRROW ET AL., HEALTH LAW: CASES, MATERIALS AND PROBLEMS 110-142 (3d ed.,
West Publishing Co. 1997).
351. Docherty, supra note 94, at 11.
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discrete psychotherapy interventions. However, despite the history of
lack of financial incentives and inability to raise funds, the picture is
changing due to new developments in the marketplace. The first is the
ability of some larger managed care organizations to provide support for
research on cost effective patient outcomes. 352
The pharmaceutical industry is also a possible partner in this research
endeavor due to a growing recognition that it could be in its economic
self interest. There is a growing awareness in the pharmaceutical
industry that the effectiveness of various medications can be enhanced
by psychotherapy, especially those forms of talk therapy that help
facilitate compliance. 353
Because the burden of proof will be on the promoters of
psychotherapeutic techniques, there will be tremendous incentive to do
good research. Despite the doomsayers, placing the burden of proof of
efficacy and safety on promoters will not throw the world into darkness.
As a result of the huge changes in the health care enterprise brought
about by managed care, there have been efforts to demonstrate the
effectiveness of different modalities of treatment. There are
movements354 within the profession to require empirically validated
treatments. There have been books written that advertise "Treatments
That Work. ' 355 Additionally, for the first time, the mental health
profession has seen the emergence of practice guidelines for the
treatments of various emotional ailments.
Requiring proof of efficacy and safety will not arrest the course of
human progress in the understanding and treatment of emotional distress
and mental illness. In fact, it will hasten it. In the last century, the
mental health profession has been responsible for tremendous advances
in the understanding and treatment of mental illness and human distress.
A small minority of the profession appears unconcerned with the need to
practice using only the best methods and techniques supported by good
research. This small minority should not be allowed to detract from the
352. Id. ("As demands to demonstrate quality improvement as well as cost control
increase, research on the utility of psychosocial interventions will be of inherent value for
the economic well-being of health care plans.")
353.. Id.
354. A Guide to Beneficial Psychotherapy, available at http://www.apa.org/divisions/
divl2/rev-est/index.shtml/(last visited Aug. 24, 2002). A task force within Division 12 of
the American Psychological Association has, since 1995, studied the research literature on
empirically validated psychotherapies for the purpose of training the profession and
producing treatment protocols.
355. A GUIDE To TREATMENTS THAT WORK 3 (Peter E. Nathan & Jack M. Gorman eds.,
Oxford University Press 1998).
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tremendous accomplishments of the profession.

